@ARTICLE{Sanchez-Garcia2016-rf,
  title    = "Recombinant pharmaceuticals from microbial cells: a 2015 update",
  author   = "Sanchez-Garcia, Laura and Mart{\'{i}}n, Lucas and Mangues, Ramon
              and Ferrer-Miralles, Neus and V{\'{a}}zquez, Esther and Villaverde,
              Antonio",
  abstract = "Diabetes, growth or clotting disorders are among the spectrum of
              human diseases related to protein absence or malfunction. Since
              these pathologies cannot be yet regularly treated by gene
              therapy, the administration of functional proteins produced ex
              vivo is required. As both protein extraction from natural
              producers and chemical synthesis undergo inherent constraints
              that limit regular large-scale production, recombinant DNA
              technologies have rapidly become a choice for therapeutic protein
              production. The spectrum of organisms exploited as recombinant
              cell factories has expanded from the early predominating
              Escherichia coli to alternative bacteria, yeasts, insect cells
              and especially mammalian cells, which benefit from metabolic and
              protein processing pathways similar to those in human cells. Up
              to date, around 650 protein drugs have been worldwide approved,
              among which about 400 are obtained by recombinant technologies.
              Other 1300 recombinant pharmaceuticals are under development,
              with a clear tendency towards engineered versions with improved
              performance and new functionalities regarding the conventional,
              plain protein species. This trend is exemplified by the
              examination of the contemporary protein-based drugs developed for
              cancer treatment.",
  journal  = "Microb. Cell Fact.",
  volume   =  15,
  pages    = "33",
  month    =  feb,
  year     =  2016,
  language = "en"
}

@ARTICLE{Wang2017-iq,
  title     = "Exploring the potential of Saccharomyces cerevisiae for
               biopharmaceutical protein production",
  author    = "Wang, Guokun and Huang, Mingtao and Nielsen, Jens",
  abstract  = "Production of recombinant proteins by yeast plays a vital role
               in the biopharmaceutical industry. It is therefore desirable to
               develop yeast platform strains for over-production of various
               biopharmaceutical proteins, but this requires fundamental
               knowledge of the cellular machinery, especially the protein
               secretory pathway. Integrated analyses of multi-omics datasets
               can provide comprehensive understanding of cellular function,
               and can enable systems biology-driven and mathematical
               model-guided strain engineering. Rational engineering and
               introduction of trackable genetic modifications using synthetic
               biology tools, coupled with high-throughput screening are,
               however, also efficient approaches to relieve bottlenecks
               hindering high-level protein production. Here we review advances
               in systems biology and metabolic engineering of yeast for
               improving recombinant protein production.",
  journal   = "Curr. Opin. Biotechnol.",
  publisher = "Elsevier",
  volume    =  48,
  pages     = "77--84",
  month     =  apr,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Kim2015-em,
  title       = "Yeast synthetic biology for the production of recombinant
                 therapeutic proteins",
  author      = "Kim, Hyunah and Yoo, Su Jin and Kang, Hyun Ah",
  abstract    = "The production of recombinant therapeutic proteins is one of
                 the fast-growing areas of molecular medicine and currently
                 plays an important role in treatment of several diseases.
                 Yeasts are unicellular eukaryotic microbial host cells that
                 offer unique advantages in producing biopharmaceutical
                 proteins. Yeasts are capable of robust growth on simple media,
                 readily accommodate genetic modifications, and incorporate
                 typical eukaryotic post-translational modifications.
                 Saccharomyces cerevisiae is a traditional baker's yeast that
                 has been used as a major host for the production of
                 biopharmaceuticals; however, several nonconventional yeast
                 species including Hansenula polymorpha, Pichia pastoris, and
                 Yarrowia lipolytica have gained increasing attention as
                 alternative hosts for the industrial production of recombinant
                 proteins. In this review, we address the established and
                 emerging genetic tools and host strains suitable for
                 recombinant protein production in various yeast expression
                 systems, particularly focusing on current efforts toward
                 synthetic biology approaches in developing yeast cell
                 factories for the production of therapeutic recombinant
                 proteins.",
  journal     = "FEMS Yeast Res.",
  volume      =  15,
  number      =  1,
  pages       = "1--16",
  month       =  feb,
  year        =  2015,
  keywords    = "biopharmaceuticals; glycoengineering; recombinant protein;
                 secretory pathway engineering; yeast cell factory",
  language    = "en",
  original_id = "f72a5b4c-e3ca-0010-8d00-a728dbbda279"
}

@ARTICLE{Delic2013-cr,
  title    = "The secretory pathway: exploring yeast diversity",
  author   = "Delic, Marizela and Valli, Minoska and Graf, Alexandra B and
              Pfeffer, Martin and Mattanovich, Diethard and Gasser, Brigitte",
  abstract = "Protein secretion is an essential process for living organisms.
              In eukaryotes, this encompasses numerous steps mediated by
              several hundred cellular proteins. The core functions of
              translocation through the endoplasmic reticulum membrane, primary
              glycosylation, folding and quality control, and vesicle-mediated
              secretion are similar from yeasts to higher eukaryotes. However,
              recent research has revealed significant functional differences
              between yeasts and mammalian cells, and even among diverse yeast
              species. This review provides a current overview of the canonical
              protein secretion pathway in the model yeast Saccharomyces
              cerevisiae, highlighting differences to mammalian cells as well
              as currently unresolved questions, and provides a genomic
              comparison of the S. cerevisiae pathway to seven other yeast
              species where secretion has been investigated due to their
              attraction as protein production platforms, or for their
              relevance as pathogens. The analysis of Candida albicans, Candida
              glabrata, Kluyveromyces lactis, Pichia pastoris, Hansenula
              polymorpha, Yarrowia lipolytica, and Schizosaccharomyces pombe
              reveals that many - but not all - secretion steps are more
              redundant in S. cerevisiae due to duplicated genes, while some
              processes are even absent in this model yeast. Recent research
              obviates that even where homologous genes are present, small
              differences in protein sequence and/or differences in the
              regulation of gene expression may lead to quite different protein
              secretion phenotypes.",
  journal  = "FEMS Microbiol. Rev.",
  volume   =  37,
  number   =  6,
  pages    = "872--914",
  month    =  nov,
  year     =  2013,
  keywords = "endoplasmic reticulum-associated degradation; glycosylation;
              protein folding; protein secretion; translocation; vesicle
              transport",
  language = "en"
}

@ARTICLE{Structural_Genomics_Consortium2008-lh,
  title    = "Protein production and purification",
  author   = "{Structural Genomics Consortium} and {China Structural Genomics
              Consortium} and {Northeast Structural Genomics Consortium} and
              Gr{\"a}slund, Susanne and Nordlund, P{\"a}r and Weigelt, Johan
              and Hallberg, B Martin and Bray, James and Gileadi, Opher and
              Knapp, Stefan and Oppermann, Udo and Arrowsmith, Cheryl and Hui,
              Raymond and Ming, Jinrong and dhe-Paganon, Sirano and Park,
              Hee-Won and Savchenko, Alexei and Yee, Adelinda and Edwards, Aled
              and Vincentelli, Renaud and Cambillau, Christian and Kim,
              Rosalind and Kim, Sung-Hou and Rao, Zihe and Shi, Yunyu and
              Terwilliger, Thomas C and Kim, Chang-Yub and Hung, Li-Wei and
              Waldo, Geoffrey S and Peleg, Yoav and Albeck, Shira and Unger,
              Tamar and Dym, Orly and Prilusky, Jaime and Sussman, Joel L and
              Stevens, Ray C and Lesley, Scott A and Wilson, Ian A and
              Joachimiak, Andrzej and Collart, Frank and Dementieva, Irina and
              Donnelly, Mark I and Eschenfeldt, William H and Kim, Youngchang
              and Stols, Lucy and Wu, Ruying and Zhou, Min and Burley, Stephen
              K and Emtage, J Spencer and Sauder, J Michael and Thompson, Devon
              and Bain, Kevin and Luz, John and Gheyi, Tarun and Zhang, Fred
              and Atwell, Shane and Almo, Steven C and Bonanno, Jeffrey B and
              Fiser, Andras and Swaminathan, Sivasubramanian and Studier, F
              William and Chance, Mark R and Sali, Andrej and Acton, Thomas B
              and Xiao, Rong and Zhao, Li and Ma, Li Chung and Hunt, John F and
              Tong, Liang and Cunningham, Kellie and Inouye, Masayori and
              Anderson, Stephen and Janjua, Heleema and Shastry, Ritu and Ho,
              Chi Kent and Wang, Dongyan and Wang, Huang and Jiang, Mei and
              Montelione, Gaetano T and Stuart, David I and Owens, Raymond J
              and Daenke, Susan and Sch{\"u}tz, Anja and Heinemann, Udo and
              Yokoyama, Shigeyuki and B{\"u}ssow, Konrad and Gunsalus, Kristin
              C",
  abstract = "In selecting a method to produce a recombinant protein, a
              researcher is faced with a bewildering array of choices as to
              where to start. To facilitate decision-making, we describe a
              consensus 'what to try first' strategy based on our collective
              analysis of the expression and purification of over 10,000
              different proteins. This review presents methods that could be
              applied at the outset of any project, a prioritized list of
              alternate strategies and a list of pitfalls that trip many new
              investigators.",
  journal  = "Nat. Methods",
  volume   =  5,
  number   =  2,
  pages    = "135--146",
  month    =  feb,
  year     =  2008,
  language = "en"
}

@ARTICLE{Owczarek2019-jg,
  title    = "A Brief Reminder of Systems of Production and
              {Chromatography-Based} Recovery of Recombinant Protein
              Biopharmaceuticals",
  author   = "Owczarek, B and Gerszberg, A and Hnatuszko-Konka, K",
  abstract = "Recombinant proteins are produced for various applications in
              laboratory and industrial settings. Among them, therapeutic
              applications have evolved into a mature field in recent years,
              affecting the face of contemporary medical treatment. This, in
              turn, has stimulated an ever-greater need for innovative
              technologies for the description, expression, and purification of
              recombinant protein biopharmaceuticals. Therefore, many
              biopharmaceuticals are synthesized in heterologous systems to
              obtain satisfactory yields that cannot be provided by natural
              sources. As more than 35 years has passed since the first
              recombinant biopharmaceutical (human insulin) successfully
              completed clinical trials in humans, we provide a brief review of
              the available prokaryotic and eukaryotic expression systems,
              listing the advantages and disadvantages of their use. Some
              examples of therapeutic proteins expressed in heterologous hosts
              are also provided. Moreover, technologies for the universal
              extraction of protein molecules are mentioned here, as is the
              methodology of their purification.",
  journal  = "Biomed Res. Int.",
  volume   =  2019,
  pages    = "4216060",
  month    =  jan,
  year     =  2019,
  language = "en"
}

@ARTICLE{Nyathi2013-zf,
  title    = "Co-translational targeting and translocation of proteins to the
              endoplasmic reticulum",
  author   = "Nyathi, Yvonne and Wilkinson, Barrie M and Pool, Martin R",
  abstract = "Co-translational protein targeting to the endoplasmic reticulum
              (ER), represents an evolutionary-conserved mechanism to target
              proteins into the secretory pathway. In this targeting pathway
              proteins possessing signal sequences are recognised at the
              ribosome by the signal recognition particle while they are still
              undergoing synthesis. This triggers their delivery to the ER
              protein translocation channel, where they are directly
              translocated into the ER. Here we review the current
              understanding of this translocation pathway and how molecular
              details obtained in the related bacterial system have provided
              insight into the mechanism of targeting and translocation. This
              article is part of a Special Issue entitled: Functional and
              structural diversity of endoplasmic reticulum.",
  journal  = "Biochim. Biophys. Acta",
  volume   =  1833,
  number   =  11,
  pages    = "2392--2402",
  month    =  nov,
  year     =  2013,
  keywords = "5â€²-guanylyl imidodiphosphate; BiP; ER; GppNHp; OST; Protein
              biogenesis; Protein targeting; Protein translocation; RAMP4; RNC;
              Ribosome; SPase; SR; SRP; Signal recognition particle; TM; TRAM;
              TRAP; Translocon; binding immunoglobulin protein; endoplasmic
              reticulum; oligosaccharyl transferase; rRNA; ribosomal RNA;
              ribosome nascent chain complex; ribosome-associated membrane
              protein 4; ribosome-nascent chain complex; signal peptidase;
              signal recognition particle; signal recognition particle
              receptor; tRNA; transfer RNA; translocating chain-associated
              membrane protein; translocon-associated protein complex;
              transmembrane helix",
  language = "en"
}

@ARTICLE{Love2012-jk,
  title       = "Systematic {Single-Cell} Analysis of Pichia pastoris Reveals
                 Secretory Capacity Limits Productivity",
  author      = "Love, Kerry Routenberg and Politano, Timothy J and Panagiotou,
                 Vasiliki and Jiang, Bo and Stadheim, Terrance A and
                 Christopher Love, J",
  abstract    = "Biopharmaceuticals represent the fastest growing sector of the
                 global pharmaceutical industry. Cost-efficient production of
                 these biologic drugs requires a robust host organism for
                 generating high titers of protein during fermentation.
                 Understanding key cellular processes that limit protein
                 production and secretion is, therefore, essential for rational
                 strain engineering. Here, with single-cell resolution, we
                 systematically analysed the productivity of a series of Pichia
                 pastoris strains that produce different proteins both
                 constitutively and inducibly. We characterized each strain by
                 qPCR, RT-qPCR, microengraving, and imaging cytometry. We then
                 developed a simple mathematical model describing the flux of
                 folded protein through the ER. This combination of single-cell
                 measurements and computational modelling shows that protein
                 trafficking through the secretory machinery is often the
                 rate-limiting step in single-cell production, and strategies
                 to enhance the overall capacity of protein secretion within
                 hosts for the production of heterologous proteins may improve
                 productivity.",
  journal     = "PLoS One",
  publisher   = "Public Library of Science",
  volume      =  7,
  number      =  6,
  pages       = "e37915",
  month       =  jun,
  year        =  2012,
  original_id = "e4a788bd-d427-0270-a933-7a803152d871"
}

@ARTICLE{Zahrl2018-dv,
  title    = "The impact of {ERAD} on recombinant protein secretion in Pichia
              pastoris (syn Komagataella spp.)",
  author   = "Zahrl, Richard J and Mattanovich, Diethard and Gasser, Brigitte",
  abstract = "The yeast Pichia pastoris (syn. Komagataella spp.) is a popular
              cell factory for recombinant protein production. Yeasts in
              general provide a good starting point for cell factory
              engineering. They are intrinsically robust and easy to manipulate
              and cultivate. However, their secretory pathway is not
              evolutionarily adapted to high loads of secretory protein. In
              particular, more complex proteins, like the antibody fragment
              (Fab) used in this study, overwhelm the folding and secretion
              capacity. This triggers cellular stress responses, which may
              cause excessive intracellular degradation. Previous results have
              shown that, in fact, about 60 \% of the newly synthesized Fab is
              intracellularly degraded. Endoplasmic reticulum-associated
              protein degradation (ERAD) is one possible intracellular
              degradation pathway for proteins aimed for secretion. We
              therefore targeted ERAD for cell factory engineering and
              investigated the impact on recombinant protein secretion in P.
              pastoris. Three components of the ERAD-L complex, which is
              involved in the degradation of luminal proteins, and a protein
              involved in proteasomal degradation, were successfully disrupted
              in Fab-secreting P. pastoris. Contrary to expectation, the effect
              on secretion was marginal. In the course of more detailed
              investigation of the impact of ERAD, we took a closer look at the
              intracellular variants of the recombinant protein. This enabled
              us to further zero in on the issue of intracellular Fab
              degradation and exclude an overshooting ER quality control. We
              propose that a major fraction of the Fab is actually degraded
              before entering the secretory pathway.",
  journal  = "Microbiology",
  volume   =  164,
  number   =  4,
  pages    = "453--463",
  month    =  apr,
  year     =  2018,
  keywords = "cell factory engineering; endoplasmic-reticulum-associated
              protein degradation (ERAD); protein secretion; recombinant
              protein production; yeast",
  language = "en"
}

@ARTICLE{Chartron2016-mn,
  title    = "Cotranslational signal-independent {SRP} preloading during
              membrane targeting",
  author   = "Chartron, Justin W and Hunt, Katherine C L and Frydman, Judith",
  abstract = "Ribosome-associated factors must properly decode the limited
              information available in nascent polypeptides to direct them to
              their correct cellular fate. It is unclear how the low complexity
              information exposed by the nascent chain suffices for accurate
              recognition by the many factors competing for the limited surface
              near the ribosomal exit site. Questions remain even for the
              well-studied cotranslational targeting cycle to the endoplasmic
              reticulum, involving recognition of linear hydrophobic signal
              sequences or transmembrane domains by the signal recognition
              particle (SRP). Notably, the SRP has low abundance relative to
              the large number of ribosome-nascent-chain complexes (RNCs), yet
              it accurately selects those destined for the endoplasmic
              reticulum. Despite their overlapping specificities, the SRP and
              the cotranslationally acting Hsp70 display precise mutually
              exclusive selectivity in vivo for their cognate RNCs. To
              understand cotranslational nascent chain recognition in vivo,
              here we investigate the cotranslational membrane-targeting cycle
              using ribosome profiling in yeast cells coupled with biochemical
              fractionation of ribosome populations. We show that the SRP
              preferentially binds secretory RNCs before their targeting
              signals are translated. Non-coding mRNA elements can promote this
              signal-independent pre-recruitment of SRP. Our study defines the
              complex kinetic interaction between elongation in the cytosol and
              determinants in the polypeptide and mRNA that modulate
              SRP--substrate selection and membrane targeting.",
  journal  = "Nature",
  volume   =  536,
  number   =  7615,
  pages    = "224--228",
  month    =  aug,
  year     =  2016,
  language = "en"
}

@ARTICLE{Love2017-qa,
  title     = "The yeast stands alone: the future of protein biologic
               production",
  author    = "Love, Kerry R and Dalvie, Neil C and Love, J Christopher",
  abstract  = "Yeasts are promising alternative hosts for the manufacturing of
               recombinant protein therapeutics because they simply and
               efficiently meet needs for both platform and small-market drugs.
               Fast accumulation of biomass and low-cost media reduce the
               cost-of-goods when using yeast, which in turn can enable agile,
               small-volume manufacturing facilities. Small, tractable yeast
               genomes are amenable to rapid process development, facilitating
               strain and product quality by design. Specifically, Pichia
               pastoris is becoming a widely accepted yeast for
               biopharmaceutical manufacturing in much of the world owing to a
               clean secreted product and the rapidly expanding understanding
               of its cell biology as a host organism. We advocate for a near
               term partnership spanning industry and academia to promote open
               source, timely development of yeast hosts.",
  journal   = "Curr. Opin. Biotechnol.",
  publisher = "Elsevier",
  volume    =  53,
  pages     = "50--58",
  month     =  dec,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Freskgard2017-ar,
  title    = "Antibody therapies in {CNS} diseases",
  author   = "Freskg{\aa}rd, Per-Ola and Urich, Eduard",
  abstract = "Therapeutic antibodies have essentially been banned from the
              central nervous system, and are so far limited to use mainly in
              multiple sclerosis. This is primarily due to the fact that
              antibody penetration across the blood-brain barrier is very
              limited, with about only 0.1\% of circulating antibodies
              estimated to reach the brain at steady-state concentration.
              Nonetheless, advances are being made with conventional
              antibodies, showing that minimal exposure can act centrally to
              mediate therapeutic effects. Immunotherapy in Alzheimer's disease
              is a noteworthy example where antibodies against amyloid-$\beta$
              are able to reduce brain plaque pathology in preclinical models
              and humans. However, the advances in using antibodies directed at
              brain targets have also demonstrated impediments of low brain
              exposure in achieving clinical benefits, spurring increased
              attention in technologies designed to improve brain exposure of
              antibodies. Here we review antibodies in clinical trials for
              central nervous system disorders. Moreover, we describe some of
              the efforts to improve the therapeutic efficacy of antibodies by
              enhancing delivery across the blood-brain barrier. This article
              is part of the Special Issue entitled ``Beyond small molecules
              for neurological disorders''.",
  journal  = "Neuropharmacology",
  volume   =  120,
  pages    = "38--55",
  month    =  jul,
  year     =  2017,
  keywords = "Alzheimer's disease; Blood-brain barrier; Delivery; Therapeutic
              antibodies",
  language = "en"
}

@ARTICLE{Yu2018-sl,
  title    = "Market share and costs of biologic therapies for inflammatory
              bowel disease in the {USA}",
  author   = "Yu, H and MacIsaac, D and Wong, J J and Sellers, Z M and Wren, A
              A and Bensen, R and Kin, C and Park, K T",
  abstract = "BACKGROUND: Real-world data quantifying the costs of increasing
              use of biologics in inflammatory bowel disease (IBD) are unknown.
              AIM: To determine the outpatient IBD drug utilization trends,
              relative market share, and costs in the USA during a 9-year
              period. METHODS: The Truven MarketScan\textregistered{} Database
              was analysed for patients with Crohn's disease (CD) and
              ulcerative colitis (UC) during 2007-2015. National drug codes
              were used to identify prescription drugs; Healthcare Common
              Procedure Coding System J-codes were used to capture biologic
              out-patient infusions. Proportion of drug usage, relative market
              share and per-member per-year (PMPY) costs were analysed for
              biologics, immunomodulators, 5-ASAs and corticosteroids. RESULTS:
              In 415 405 patients (188 842 CD; 195 183 UC; 31 380 indeterminate
              colitis; 54.67\% female), utilization trends show a consistent
              rise in the market share of biologics during the 9-year study
              period. The proportion of patients using biologics increased from
              21.8\% to 43.8\% for CD and 5.1\%-16.2\% for UC. This contrasts a
              small decrease in immunomodulator and 5-ASA use for CD and
              relative constancy of other classes including
              corticosteroids-only use as primary IBD medication from 2007 to
              2015. The average biologic-taking patient accounted for $25 275
              PMPY in 2007 and $36 051 PMPY in 2015. The average paediatric
              biologic-taking patient accounted for $23 616 PMPY in 2007 and
              $41 109 PMPY in 2015. In all patients, the share of costs for
              biologics increased from 72.9\% in 2007 to 85.7\% in 2015 (81.7\%
              in 2007 to 94.9\% in 2015 in paediatrics). CONCLUSION: The vast
              majority of costs allocated to out-patient IBD medications in the
              USA is attributed to increasing use of biologic therapies despite
              the relative minority of biologic-taking patients.",
  journal  = "Aliment. Pharmacol. Ther.",
  volume   =  47,
  number   =  3,
  pages    = "364--370",
  month    =  feb,
  year     =  2018,
  language = "en"
}

@ARTICLE{Koren2017-td,
  title    = "Long-term {Low-Density} Lipoprotein {Cholesterol-Lowering}
              Efficacy, Persistence, and Safety of Evolocumab in Treatment of
              Hypercholesterolemia: Results Up to 4 Years From the {Open-Label}
              {OSLER-1} Extension Study",
  author   = "Koren, Michael J and Sabatine, Marc S and Giugliano, Robert P and
              Langslet, Gisle and Wiviott, Stephen D and Kassahun, Helina and
              Ruzza, Andrea and Ma, Yuhui and Somaratne, Ransi and Raal,
              Frederick J",
  abstract = "Importance: The Open-Label Study of Long-term Evaluation Against
              LDL-C (OSLER-1) evaluated the durability of long-term efficacy
              and safety during long-term therapy with evolocumab, a monoclonal
              antibody against proprotein convertase subtilisin/kexin type 9
              (PCSK9). Objective: To determine whether LDL-C level reductions
              with evolocumab persist across different populations. Secondary
              objectives included assessment of adverse events, antidrug
              antibodies, and factors contributing to treatment
              discontinuation. Design, Setting, and Participants: This ongoing,
              randomized open-label extension trial (OSLER-1) was conducted at
              192 sites in 18 countries. A total of 1324 of 1666 patients
              randomized into 1 of 5 12-week double-blind phase 2 parent
              studies completed a parent study and chose to participate in
              OSLER-1; 1255 received 1 or more evolocumab doses. As of August
              2016, 812 of 1324 (61\%) had 208 weeks of follow-up. This current
              study was conducted from October 2011 to August 2016, with a data
              cutoff of August 26, 2016. Interventions: During year 1, patients
              were randomized to evolocumab, 420 mg, plus standard of care
              (SOC) or SOC alone. After year 1, all patients continuing the
              study received evolocumab, 420 mg, plus SOC. Main Outcomes and
              Measures: Lipids, safety, and tolerability every 12 weeks. A
              multivariate model identified factors associated with
              discontinuation of evolocumab. Results: At parent study baseline,
              the mean (SD) age of the population was 57.1 (11.6) years, with
              52.9\% being women. The median LDL-C level was 133 mg/dL (to
              convert to millimoles per liter, multiply by 0.0259). After 52
              weeks, evolocumab plus SOC was associated with a significant
              reduction in LDL-C level by 61\% (95\% CI, -63\% to -60\%) vs 2\%
              (95\% CI, -5\% to -0.2\%) with SOC alone (P < .001). At
              approximately 2, 3, and 4 years of study follow-up, the median
              LDL-C level was reduced by 59\% (95\% CI, -60\% to -57\%), 59\%
              (95\% CI, -61\% to -58\%), and 57\% (95\% CI, -59\% to -55\%),
              respectively, from parent study baseline. For patients receiving
              statin therapy unchanged from baseline, at week 208, the median
              LDL-C level reduction was 58\%. No neutralizing antibodies to
              evolocumab were detected. The annualized incidence of new-onset
              diabetes was 4\% in the SOC alone group and, adjusting for
              duration of evolocumab exposure, 2.8\% in the evolocumab plus SOC
              group. Neurocognitive event rates were 0\% (SOC alone) and 0.4\%
              (evolocumab plus SOC). A total of 79\% of patients persisted with
              evolocumab treatment, with a mean exposure duration of 44 months.
              Conclusions and Relevance: In the longest clinical trial exposure
              to a PCSK9 inhibitor to date, evolocumab produced sustained
              reductions in LDL-C levels. The annual frequency of adverse
              events did not occur more frequently with cumulative exposure
              during open-label observation. Trial Registration:
              clinicaltrials.gov Identifier: NCT01439880.",
  journal  = "JAMA Cardiol",
  volume   =  2,
  number   =  6,
  pages    = "598--607",
  month    =  jun,
  year     =  2017,
  language = "en"
}

@ARTICLE{Xu2017-rd,
  title    = "Trispecific broadly neutralizing {HIV} antibodies mediate potent
              {SHIV} protection in macaques",
  author   = "Xu, Ling and Pegu, Amarendra and Rao, Ercole and Doria-Rose,
              Nicole and Beninga, Jochen and McKee, Krisha and Lord, Dana M and
              Wei, Ronnie R and Deng, Gejing and Louder, Mark and Schmidt,
              Stephen D and Mankoff, Zachary and Wu, Lan and Asokan,
              Mangaiarkarasi and Beil, Christian and Lange, Christian and
              Leuschner, Wulf Dirk and Kruip, Jochen and Sendak, Rebecca and
              Kwon, Young Do and Zhou, Tongqing and Chen, Xuejun and Bailer,
              Robert T and Wang, Keyun and Choe, Misook and Tartaglia, Lawrence
              J and Barouch, Dan H and O'Dell, Sijy and Todd, John-Paul and
              Burton, Dennis R and Roederer, Mario and Connors, Mark and Koup,
              Richard A and Kwong, Peter D and Yang, Zhi-Yong and Mascola, John
              R and Nabel, Gary J",
  abstract = "The development of an effective AIDS vaccine has been challenging
              because of viral genetic diversity and the difficulty of
              generating broadly neutralizing antibodies (bnAbs). We engineered
              trispecific antibodies (Abs) that allow a single molecule to
              interact with three independent HIV-1 envelope determinants: the
              CD4 binding site, the membrane-proximal external region (MPER),
              and the V1V2 glycan site. Trispecific Abs exhibited higher
              potency and breadth than any previously described single bnAb,
              showed pharmacokinetics similar to those of human bnAbs, and
              conferred complete immunity against a mixture of simian-human
              immunodeficiency viruses (SHIVs) in nonhuman primates, in
              contrast to single bnAbs. Trispecific Abs thus constitute a
              platform to engage multiple therapeutic targets through a single
              protein, and they may be applicable for treatment of diverse
              diseases, including infections, cancer, and autoimmunity.",
  journal  = "Science",
  volume   =  358,
  number   =  6359,
  pages    = "85--90",
  month    =  oct,
  year     =  2017,
  language = "en"
}

@ARTICLE{Kallehauge2017-nr,
  title    = "Ribosome profiling-guided depletion of an {mRNA} increases cell
              growth rate and protein secretion",
  author   = "Kallehauge, Thomas Beuchert and Li, Shangzhong and Pedersen,
              Lasse Ebdrup and Ha, Tae Kwang and Ley, Daniel and Andersen,
              Mikael R{\o}rdam and Kildegaard, Helene Faustrup and Lee, Gyun
              Min and Lewis, Nathan E",
  abstract = "Recombinant protein production coopts the host cell machinery to
              provide high protein yields of industrial enzymes or
              biotherapeutics. However, since protein translation is
              energetically expensive and tightly controlled, it is unclear if
              highly expressed recombinant genes are translated as efficiently
              as host genes. Furthermore, it is unclear how the high expression
              impacts global translation. Here, we present the first
              genome-wide view of protein translation in an IgG-producing CHO
              cell line, measured with ribosome profiling. Through this we
              found that our recombinant mRNAs were translated as efficiently
              as the host cell transcriptome, and sequestered up to 15\% of the
              total ribosome occupancy. During cell culture, changes in
              recombinant mRNA translation were consistent with changes in
              transcription, demonstrating that transcript levels influence
              specific productivity. Using this information, we identified the
              unnecessary resistance marker NeoR to be a highly transcribed and
              translated gene. Through siRNA knock-down of NeoR, we improved
              the production- and growth capacity of the host cell. Thus,
              ribosomal profiling provides valuable insights into translation
              in CHO cells and can guide efforts to enhance protein production.",
  journal  = "Sci. Rep.",
  volume   =  7,
  pages    = "40388",
  month    =  jan,
  year     =  2017,
  language = "en"
}

@ARTICLE{Salari2017-xq,
  title    = "Investigation of the Best Saccharomyces cerevisiae Growth
              Condition",
  author   = "Salari, Roshanak and Salari, Rosita",
  abstract = "INTRODUCTION: Saccharomyces cerevisiae is known as one of the
              useful yeasts which are utilized in baking and other industries.
              It can be easily cultured at an economic price. Today the
              introduction of safe and efficient carriers is being considered.
              Due to its generally round shape, and the volume that is enclosed
              by its membrane and cell wall, it is used to encapsulate active
              materials to protect them from degradation or to introduce a
              sustained release drug delivery system. Providing the best
              conditions in order to achieve the best morphological properties
              of Saccharomyces cerevisiae as a carrier. METHODS: In this
              research, the most suitable growth condition of yeast cells which
              provides the best size for use as drug carriers was found by a
              bioreactor in a synthetic culture medium. Yeast cell reproduction
              and growth curves were obtained, based on pour plate colony
              counting data and UV/Visible sample absorption at 600 nm. Yeast
              cell growth patterns and growth rates were determined by Matlab
              mathematical software. RESULTS: Results showed that pH=4 and
              dissolving oxygen (DO) 5\% was the best condition for yeast cells
              to grow and reproduce. This condition also provided the largest
              size (2 $\times$ 3 $\mu$) yeast cells. CONCLUSION: Owing to the
              yeast cells' low-cost production and their structural
              characteristics, they could be used as potent drug carriers.
              FUNDING: This work was supported by a grant from the Vice
              Chancellor of Research of Mashhad University of Medical Sciences.",
  journal  = "Electron Physician",
  volume   =  9,
  number   =  1,
  pages    = "3592--3597",
  month    =  jan,
  year     =  2017,
  keywords = "Carrier; Growth; Mathematics; Saccharomyces cerevisiae yeast
              cells",
  language = "en"
}


@ARTICLE{Wang2014-hi,
  title    = "Improving the expression of recombinant proteins in E. coli
              {BL21} ({DE3}) under acetate stress: an alkaline pH shift
              approach",
  author   = "Wang, Hengwei and Wang, Fengqing and Wang, Wei and Yao, Xueling
              and Wei, Dongzhi and Cheng, Hairong and Deng, Zixin",
  abstract = "Excess acetate has long been an issue for the production of
              recombinant proteins in E. coli cells. Recently, improvements in
              acetate tolerance have been achieved through the use of genetic
              strategies and medium supplementation with certain amino acids
              and pyrimidines. The aim of our study was to evaluate an
              alternative to improve the acetate tolerance of E. coli BL21
              (DE3), a popular strain used to express recombinant proteins. In
              this work we reported the cultivation of BL21 (DE3) in complex
              media containing acetate at high concentrations. In the presence
              of 300 mM acetate, compared with pH 6.5, pH 7.5 improved cell
              growth by approximately 71\%, reduced intracellular acetate by
              approximately 50\%, and restored the expression of glutathione
              S-transferase (GST), green fluorescent protein (GFP) and
              cytochrome P450 monooxygenase (CYP). Further experiments showed
              that alkaline pHs up to 8.5 had little inhibition in the
              expression of GST, GFP and CYP. In addition, the detrimental
              effect of acetate on the reduction of
              3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
              (MTT) by the cell membrane, an index of cellular metabolic
              capacity, was substantially alleviated by a shift to alkaline pH
              values of 7.5-8.0. Thus, we suggest an approach of cultivating E.
              coli BL21 (DE3) at pH 8.0 $\pm$ 0.5 to minimize the effects
              caused by acetate stress. The proposed strategy of an alkaline pH
              shift is a simple approach to solving similar bioprocessing
              problems in the production of biofuels and biochemicals from
              sugars.",
  journal  = "PLoS One",
  volume   =  9,
  number   =  11,
  pages    = "e112777",
  month    =  nov,
  year     =  2014,
  language = "en"
}

@ARTICLE{Narendranath2005-wv,
  title    = "Relationship between pH and medium dissolved solids in terms of
              growth and metabolism of lactobacilli and Saccharomyces
              cerevisiae during ethanol production",
  author   = "Narendranath, Neelakantam V and Power, Ronan",
  abstract = "The specific growth rates of four species of lactobacilli
              decreased linearly with increases in the concentration of
              dissolved solids (sugars) in liquid growth medium. This was most
              likely due to the osmotic stress exerted by the sugars on the
              bacteria. The reduction in growth rates corresponded to decreased
              lactic acid production. Medium pH was another factor studied. As
              the medium pH decreased from 5.5 to 4.0, there was a reduction in
              the specific growth rate of lactobacilli and a corresponding
              decrease in the lactic acid produced. In contrast, medium pH did
              not have any significant effect on the specific growth rate of
              yeast at any particular concentration of dissolved solids in the
              medium. However, medium pH had a significant (P 0.2923) observed
              between pH of the medium and concentration of dissolved solids of
              the medium in reducing bacterial growth and metabolism. The data
              suggest that reduction of initial medium pH to 4.0 for the
              control of lactobacilli during ethanol production is not a good
              practice as there is a reduction (P or =30\% (wt/vol) dissolved
              solids at a pH of 5.0 to 5.5 will minimize the effects of
              bacterial contamination and maximize ethanol production by yeast.",
  journal  = "Appl. Environ. Microbiol.",
  volume   =  71,
  number   =  5,
  pages    = "2239--2243",
  month    =  may,
  year     =  2005,
  language = "en"
}

@ARTICLE{Gustafsson2004-qg,
  title    = "Codon bias and heterologous protein expression",
  author   = "Gustafsson, Claes and Govindarajan, Sridhar and Minshull, Jeremy",
  abstract = "The expression of functional proteins in heterologous hosts is a
              cornerstone of modern biotechnology. Unfortunately, proteins are
              often difficult to express outside their original context. They
              might contain codons that are rarely used in the desired host,
              come from organisms that use non-canonical code or contain
              expression-limiting regulatory elements within their coding
              sequence. Improvements in the speed and cost of gene synthesis
              have facilitated the complete redesign of entire gene sequences
              to maximize the likelihood of high protein expression. Redesign
              strategies are discussed here, including modification of
              translation initiation regions, alteration of mRNA structural
              elements and use of different codon biases.",
  journal  = "Trends Biotechnol.",
  volume   =  22,
  number   =  7,
  pages    = "346--353",
  month    =  jul,
  year     =  2004,
  language = "en"
}

@ARTICLE{Huang2018-ru,
  title    = "Engineering the protein secretory pathway of Saccharomyces
              cerevisiae enables improved protein production",
  author   = "Huang, Mingtao and Wang, Guokun and Qin, Jiufu and Petranovic,
              Dina and Nielsen, Jens",
  abstract = "Baker's yeast Saccharomyces cerevisiae is one of the most
              important and widely used cell factories for recombinant protein
              production. Many strategies have been applied to engineer this
              yeast for improving its protein production capacity, but
              productivity is still relatively low, and with increasing market
              demand, it is important to identify new gene targets, especially
              targets that have synergistic effects with previously identified
              targets. Despite improved protein production, previous studies
              rarely focused on processes associated with intracellular protein
              retention. Here we identified genetic modifications involved in
              the secretory and trafficking pathways, the histone deacetylase
              complex, and carbohydrate metabolic processes as targets for
              improving protein secretion in yeast. Especially modifications on
              the endosome-to-Golgi trafficking was found to effectively reduce
              protein retention besides increasing protein secretion. Through
              combinatorial genetic manipulations of several of the newly
              identified gene targets, we enhanced the protein production
              capacity of yeast by more than fivefold, and the best engineered
              strains could produce 2.5 g/L of a fungal $\alpha$-amylase with
              less than 10\% of the recombinant protein retained within the
              cells, using fed-batch cultivation.",
  journal  = "Proc. Natl. Acad. Sci. U. S. A.",
  volume   =  115,
  number   =  47,
  pages    = "E11025--E11032",
  month    =  nov,
  year     =  2018,
  keywords = "cell engineering; endosome-to-Golgi trafficking; intracellular
              protein retention; protein secretion; yeast cell factories",
  language = "en"
}

@ARTICLE{Mori2015-er,
  title    = "Signal peptide optimization tool for the secretion of recombinant
              protein from Saccharomyces cerevisiae",
  author   = "Mori, Akihiro and Hara, Shoichi and Sugahara, Tomohiro and
              Kojima, Takaaki and Iwasaki, Yugo and Kawarasaki, Yasuaki and
              Sahara, Takehiko and Ohgiya, Satoru and Nakano, Hideo",
  abstract = "The secretion efficiency of foreign proteins in recombinant
              microbes is strongly dependent on the combination of the signal
              peptides (SPs) used and the target proteins; therefore,
              identifying the optimal SP sequence for each target protein is a
              crucial step in maximizing the efficiency of protein secretion in
              both prokaryotes and eukaryotes. In this study, we developed a
              novel method, named the SP optimization tool (SPOT), for the
              generation and rapid screening of a library of SP-target gene
              fusion constructs to identify the optimal SP for maximizing
              target protein secretion. In contrast to libraries generated in
              previous studies, SPOT fusion constructs are generated without
              adding the intervening sequences associated with restriction
              enzyme digestion sites. Therefore, no extra amino acids are
              inserted at the N-terminus of the target protein that might
              affect its function or conformational stability. As a model
              system, $\beta$-galactosidase (LacA) from Aspergillus oryzae was
              used as a target protein for secretion from Saccharomyces
              cerevisiae. In total, 60 SPs were selected from S. cerevisiae
              secretory proteins and utilized to generate the SP library. While
              many of the SP-LacA fusions were not secreted, several of the
              SPs, AGA2, CRH1, PLB1, and MF(alpha)1, were found to enhance LacA
              secretion compared to the WT sequence. Our results indicate that
              SPOT is a valuable method for optimizing the bioproduction of any
              target protein, and could be adapted to many host strains.",
  journal  = "J. Biosci. Bioeng.",
  volume   =  120,
  number   =  5,
  pages    = "518--525",
  month    =  nov,
  year     =  2015,
  keywords = "Saccharomyces cerevisiae; Secretion; Signal peptide library;
              SignalP; $\beta$-Galactosidase",
  language = "en"
}

@ARTICLE{Knappskog2007-qt,
  title    = "The level of synthesis and secretion of Gaussia princeps
              luciferase in transfected {CHO} cells is heavily dependent on the
              choice of signal peptide",
  author   = "Knappskog, Stian and Ravneberg, Hanne and Gjerdrum, Christine and
              Tr{\"o}sse, Christiane and Stern, Beate and Pryme, Ian F",
  abstract = "There is a great demand for the improvement of mammalian cell
              production systems such that they can compete economically with
              their prokaryotic counterparts. Of a number of parameters that
              need to be explored to accomplish this we have tested the effects
              of different signal peptides on the synthesis and secretion of
              Gaussia princeps luciferase in mammalian cells. A series of
              plasmids were transfected into CHO cells where the coding region
              for the marine luciferase was fused to the signal peptide coding
              regions derived from different sources. Both cell extracts and
              medium samples were analysed for luciferase activity. When the
              native Gaussia luciferase signal sequence in the vector was
              substituted by that from human interleukin-2 or albumin then the
              amount of active recombinant protein produced was substantially
              reduced, both in transiently and stably transfected cells.
              Western blotting showed that enzyme activity and protein levels
              mirrored one another. The major decrease in luciferase activity
              was shown not to be a result of decreased mRNA levels, indicating
              the involvement of a post-transcriptional event. When the coding
              region of human endostatin was fused to that of the Gaussia
              luciferase signal peptide then an elevated level of secreted
              endostatin was observed compared to when that of the albumin
              signal peptide was used. Stable transfection of HepG2 cells with
              the different signal peptide constructs gave essentially the same
              results as seen in CHO cells. The overall results indicate that
              the choice of signal peptide can be imperative to ensure an
              optimal synthesis and secretion of a recombinant protein in a
              mammalian cell culture system.",
  journal  = "J. Biotechnol.",
  volume   =  128,
  number   =  4,
  pages    = "705--715",
  month    =  mar,
  year     =  2007,
  language = "en"
}

@ARTICLE{Lareau2014-vv,
  title    = "Distinct stages of the translation elongation cycle revealed by
              sequencing ribosome-protected {mRNA} fragments",
  author   = "Lareau, Liana F and Hite, Dustin H and Hogan, Gregory J and
              Brown, Patrick O",
  abstract = "During translation elongation, the ribosome ratchets along its
              mRNA template, incorporating each new amino acid and
              translocating from one codon to the next. The elongation cycle
              requires dramatic structural rearrangements of the ribosome. We
              show here that deep sequencing of ribosome-protected mRNA
              fragments reveals not only the position of each ribosome but
              also, unexpectedly, its particular stage of the elongation cycle.
              Sequencing reveals two distinct populations of ribosome
              footprints, 28-30 nucleotides and 20-22 nucleotides long,
              representing translating ribosomes in distinct states,
              differentially stabilized by specific elongation inhibitors. We
              find that the balance of small and large footprints varies by
              codon and is correlated with translation speed. The ability to
              visualize conformational changes in the ribosome during
              elongation, at single-codon resolution, provides a new way to
              study the detailed kinetics of translation and a new probe with
              which to identify the factors that affect each step in the
              elongation cycle.DOI: http://dx.doi.org/10.7554/eLife.01257.001.",
  journal  = "Elife",
  volume   =  3,
  pages    = "e01257",
  month    =  may,
  year     =  2014,
  keywords = "ribosome; ribosome profiling; translation",
  language = "en"
}

@ARTICLE{Martin2011-lc,
  title    = "Cutadapt removes adapter sequences from high-throughput
              sequencing reads",
  author   = "Martin, Marcel",
  abstract = "When small RNA is sequenced on current sequencing machines, the
              resulting reads are usually longer than the RNA and therefore
              contain parts of the 3' adapter. That adapter must be found and
              removed error-tolerantly from each read before read mapping.
              Previous solutions are either hard to use or do not offer
              required features, in particular support for color space data. As
              an easy to use alternative, we developed the command-line tool
              cutadapt, which supports 454, Illumina and SOLiD (color space)
              data, offers two adapter trimming algorithms, and has other
              useful features. Cutadapt, including its MIT-licensed source
              code, is available for download at
              http://code.google.com/p/cutadapt/",
  journal  = "EMBnet.journal",
  volume   =  17,
  number   =  1,
  pages    = "10--12",
  month    =  may,
  year     =  2011,
  keywords = "next generation sequencing; small RNA; microRNA; adapter removal",
  language = "en"
}

@MISC{noauthor_undated-cb,
  title        = "Cutadapt --- cutadapt 2.3 documentation",
  howpublished = "\url{https://cutadapt.readthedocs.io/en/stable/}",
  note         = "Accessed: 2019-5-7"
}

@ARTICLE{Kim2015-gu,
  title    = "{HISAT}: a fast spliced aligner with low memory requirements",
  author   = "Kim, Daehwan and Langmead, Ben and Salzberg, Steven L",
  abstract = "HISAT (hierarchical indexing for spliced alignment of
              transcripts) is a highly efficient system for aligning reads from
              RNA sequencing experiments. HISAT uses an indexing scheme based
              on the Burrows-Wheeler transform and the Ferragina-Manzini (FM)
              index, employing two types of indexes for alignment: a
              whole-genome FM index to anchor each alignment and numerous local
              FM indexes for very rapid extensions of these alignments. HISAT's
              hierarchical index for the human genome contains 48,000 local FM
              indexes, each representing a genomic region of âˆ¼64,000 bp. Tests
              on real and simulated data sets showed that HISAT is the fastest
              system currently available, with equal or better accuracy than
              any other method. Despite its large number of indexes, HISAT
              requires only 4.3 gigabytes of memory. HISAT supports genomes of
              any size, including those larger than 4 billion bases.",
  journal  = "Nat. Methods",
  volume   =  12,
  number   =  4,
  pages    = "357--360",
  month    =  apr,
  year     =  2015,
  language = "en"
}

@MISC{noauthor_undated-oo,
  title        = "{HISAT2}",
  abstract     = "Center for Computational Biology",
  howpublished = "\url{https://ccb.jhu.edu/software/hisat2/index.shtml}",
  note         = "Accessed: 2019-5-7"
}

@ARTICLE{Li2009-bd,
  title    = "The Sequence {Alignment/Map} format and {SAMtools}",
  author   = "Li, Heng and Handsaker, Bob and Wysoker, Alec and Fennell, Tim
              and Ruan, Jue and Homer, Nils and Marth, Gabor and Abecasis,
              Goncalo and Durbin, Richard",
  abstract = "The Sequence Alignment/Map (SAM) format is a generic alignment
              format for storing read alignments against reference sequences,
              supporting short and long reads (up to 128 Mbp) produced by
              different sequencing platforms. It is flexible in style, compact
              in size, efficient in random access and is the format in which
              alignments from the 1000 Genomes Project are released. SAMtools
              implements various utilities for post-processing alignments in
              the SAM format, such as indexing, variant caller and alignment
              viewer, and thus provides universal tools for processing read
              alignments.",
  journal  = "Bioinformatics",
  volume   =  25,
  number   =  16,
  pages    = "2078--2079",
  month    =  aug,
  year     =  2009
}

@MISC{noauthor_undated-ue,
  title        = "Samtools",
  abstract     = "Samtools",
  howpublished = "\url{http://www.htslib.org/}",
  note         = "Accessed: 2019-5-7"
}

@ARTICLE{Lawrence2013-bp,
  title    = "Software for computing and annotating genomic ranges",
  author   = "Lawrence, Michael and Huber, Wolfgang and Pag{\`e}s, Herv{\'e}
              and Aboyoun, Patrick and Carlson, Marc and Gentleman, Robert and
              Morgan, Martin T and Carey, Vincent J",
  abstract = "We describe Bioconductor infrastructure for representing and
              computing on annotated genomic ranges and integrating genomic
              data with the statistical computing features of R and its
              extensions. At the core of the infrastructure are three packages:
              IRanges, GenomicRanges, and GenomicFeatures. These packages
              provide scalable data structures for representing annotated
              ranges on the genome, with special support for transcript
              structures, read alignments and coverage vectors. Computational
              facilities include efficient algorithms for overlap and nearest
              neighbor detection, coverage calculation and other range
              operations. This infrastructure directly supports more than 80
              other Bioconductor packages, including those for sequence
              analysis, differential expression analysis and visualization.",
  journal  = "PLoS Comput. Biol.",
  volume   =  9,
  number   =  8,
  pages    = "e1003118",
  month    =  aug,
  year     =  2013,
  language = "en"
}

@ARTICLE{Popa2016-vl,
  title    = "{RiboProfiling}: a Bioconductor package for standard Ribo-seq
              pipeline processing",
  author   = "Popa, Alexandra and Lebrigand, Kevin and Paquet, Agnes and
              Nottet, Nicolas and Robbe-Sermesant, Karine and Waldmann, Rainer
              and Barbry, Pascal",
  abstract = "The ribosome profiling technique (Ribo-seq) allows the selective
              sequencing of translated RNA regions. Recently, the analysis of
              genomic sequences associated to Ribo-seq reads has been widely
              employed to assess their coding potential. These analyses led to
              the identification of differentially translated transcripts under
              different experimental conditions, and/or ribosome pausing on
              codon motifs. In the context of the ever-growing need for tools
              analyzing Ribo-seq reads, we have developed 'RiboProfiling', a
              new Bioconductor open-source package. 'RiboProfiling' provides a
              full pipeline to cover all key steps for the analysis of ribosome
              footprints. This pipeline has been implemented in a single R
              workflow. The package takes an alignment (BAM) file as input and
              performs ribosome footprint quantification at a transcript level.
              It also identifies footprint accumulation on particular amino
              acids or multi amino-acids motifs. Report summary graphs and data
              quantification are generated automatically. The package
              facilitates quality assessment and quantification of Ribo-seq
              experiments. Its implementation in Bioconductor enables the
              modeling and statistical analysis of its output through the vast
              choice of packages available in R. This article illustrates how
              to identify codon-motifs accumulating ribosome footprints, based
              on data from Escherichia coli.",
  journal  = "F1000Res.",
  volume   =  5,
  pages    = "1309",
  month    =  jun,
  year     =  2016,
  keywords = "genomics; ribosome footprints; ribosome profiling",
  language = "en"
}

@ARTICLE{Mohammad2019-sm,
  title    = "A systematically-revised ribosome profiling method for bacteria
              reveals pauses at single-codon resolution",
  author   = "Mohammad, Fuad and Green, Rachel and Buskirk, Allen R",
  abstract = "In eukaryotes, ribosome profiling provides insight into the
              mechanism of protein synthesis at the codon level. In bacteria,
              however, the method has been more problematic and no consensus
              has emerged for how to best prepare profiling samples. Here, we
              identify the sources of these problems and describe new solutions
              for arresting translation and harvesting cells in order to
              overcome them. These improvements remove confounding artifacts
              and improve the resolution to allow analyses of ribosome behavior
              at the codon level. With a clearer view of the translational
              landscape in vivo, we observe that filtering cultures leads to
              translational pauses at serine and glycine codons through the
              reduction of tRNA aminoacylation levels. This observation
              illustrates how bacterial ribosome profiling studies can yield
              insight into the mechanism of protein synthesis at the codon
              level and how these mechanisms are regulated in response to
              changes in the physiology of the cell.",
  journal  = "Elife",
  volume   =  8,
  month    =  feb,
  year     =  2019,
  keywords = "E. coli; bacteria; biochemistry; chemical biology; chromosomes;
              gene expression; pausing; ribosome profiling; serine",
  language = "en"
}

@ARTICLE{Gasser2013-ef,
  title       = "Pichia pastoris: protein production host and model organism
                 for biomedical research",
  author      = "Gasser, Brigitte and Prielhofer, Roland and Marx, Hans and
                 Maurer, Michael and Nocon, Justyna and Steiger, Matthias and
                 Puxbaum, Verena and Sauer, Michael and Mattanovich, Diethard",
  abstract    = "Pichia pastoris is the most frequently used yeast system for
                 heterologous protein production today. The last few years have
                 seen several products based on this platform reach approval as
                 biopharmaceutical drugs. Successful glycoengineering to
                 humanize N-glycans is further fuelling this development.
                 However, detailed understanding of the yeast's physiology,
                 genetics and regulation has only developed rapidly in the last
                 few years since published genome sequences have become
                 available. An expanding toolbox of genetic elements and
                 strains for the improvement of protein production is being
                 generated, including promoters, gene copy-number enhancement,
                 gene knockout and high-throughput methods. Protein folding and
                 secretion have been identified as significant bottlenecks in
                 yeast expression systems, pinpointing a major target for
                 strain optimization. At the same time, it has become obvious
                 that P. pastoris, as an evolutionarily more 'ancient' yeast,
                 may in some cases be a better model for human cell biology and
                 disease than Saccharomyces cerevisiae.",
  journal     = "Future Microbiol.",
  volume      =  8,
  number      =  2,
  pages       = "191--208",
  month       =  feb,
  year        =  2013,
  language    = "en",
  original_id = "da05cf88-35f2-0973-9de6-da47c8abec11"
}

@ARTICLE{Le_Crom2009-zp,
  title    = "Tracking the roots of cellulase hyperproduction by the fungus
              Trichoderma reesei using massively parallel {DNA} sequencing",
  author   = "Le Crom, St{\'e}phane and Schackwitz, Wendy and Pennacchio, Len
              and Magnuson, Jon K and Culley, David E and Collett, James R and
              Martin, Joel and Druzhinina, Irina S and Mathis, Hugues and
              Monot, Fr{\'e}d{\'e}ric and Seiboth, Bernhard and Cherry, Barbara
              and Rey, Michael and Berka, Randy and Kubicek, Christian P and
              Baker, Scott E and Margeot, Antoine",
  abstract = "Trichoderma reesei (teleomorph Hypocrea jecorina) is the main
              industrial source of cellulases and hemicellulases harnessed for
              the hydrolysis of biomass to simple sugars, which can then be
              converted to biofuels such as ethanol and other chemicals. The
              highly productive strains in use today were generated by
              classical mutagenesis. To learn how cellulase production was
              improved by these techniques, we performed massively parallel
              sequencing to identify mutations in the genomes of two
              hyperproducing strains (NG14, and its direct improved descendant,
              RUT C30). We detected a surprisingly high number of mutagenic
              events: 223 single nucleotides variants, 15 small deletions or
              insertions, and 18 larger deletions, leading to the loss of more
              than 100 kb of genomic DNA. From these events, we report
              previously undocumented non-synonymous mutations in 43 genes that
              are mainly involved in nuclear transport, mRNA stability,
              transcription, secretion/vacuolar targeting, and metabolism. This
              homogeneity of functional categories suggests that multiple
              changes are necessary to improve cellulase production and not
              simply a few clear-cut mutagenic events. Phenotype microarrays
              show that some of these mutations result in strong changes in the
              carbon assimilation pattern of the two mutants with respect to
              the wild-type strain QM6a. Our analysis provides genome-wide
              insights into the changes induced by classical mutagenesis in a
              filamentous fungus and suggests areas for the generation of
              enhanced T. reesei strains for industrial applications such as
              biofuel production.",
  journal  = "Proc. Natl. Acad. Sci. U. S. A.",
  volume   =  106,
  number   =  38,
  pages    = "16151--16156",
  month    =  sep,
  year     =  2009,
  language = "en"
}

@ARTICLE{Radecka2015-mq,
  title       = "Looking beyond Saccharomyces: the potential of
                 non-conventional yeast species for desirable traits in
                 bioethanol fermentation",
  author      = "Radecka, Dorota and Mukherjee, Vaskar and Mateo, Raquel
                 Quintilla and Stojiljkovic, Marija and Foulqui{\'e}-Moreno,
                 Mar{\'\i}a R and Thevelein, Johan M",
  abstract    = "Saccharomyces cerevisiae has been used for millennia in the
                 production of food and beverages and is by far the most
                 studied yeast species. Currently, it is also the most used
                 microorganism in the production of first-generation bioethanol
                 from sugar or starch crops. Second-generation bioethanol, on
                 the other hand, is produced from lignocellulosic feedstocks
                 that are pretreated and hydrolyzed to obtain monomeric sugars,
                 mainly D-glucose, D-xylose and L-arabinose. Recently, S.
                 cerevisiae recombinant strains capable of fermenting pentose
                 sugars have been generated. However, the pretreatment of the
                 biomass results in hydrolysates with high osmolarity and high
                 concentrations of inhibitors. These compounds negatively
                 influence the fermentation process. Therefore, robust strains
                 with high stress tolerance are required. Up to now, more than
                 2000 yeast species have been described and some of these could
                 provide a solution to these limitations because of their high
                 tolerance to the most predominant stress conditions present in
                 a second-generation bioethanol reactor. In this review, we
                 will summarize what is known about the non-conventional yeast
                 species showing unusual tolerance to these stresses, namely
                 Zygosaccharomyces rouxii (osmotolerance), Kluyveromyces
                 marxianus and Ogataea (Hansenula) polymorpha
                 (thermotolerance), Dekkera bruxellensis (ethanol tolerance),
                 Pichia kudriavzevii (furan derivatives tolerance) and Z.
                 bailii (acetic acid tolerance).",
  journal     = "FEMS Yeast Res.",
  volume      =  15,
  number      =  6,
  month       =  sep,
  year        =  2015,
  keywords    = "bioethanol; non-Saccharomyces; phenotype; stress tolerance;
                 yeasts",
  language    = "en",
  original_id = "71781ecb-27a2-059e-8562-279994c80fe6"
}

@MISC{noauthor_undated-vw,
  title        = "Saccharomyces Genome Database | {SGD}",
  abstract     = "The Saccharomyces Genome Database (SGD) provides
                  comprehensive integrated biological information for the
                  budding yeast Saccharomyces cerevisiae.",
  howpublished = "\url{https://www.yeastgenome.org/}",
  note         = "Accessed: 2019-9-26"
}

@MISC{noauthor_undated-lc,
  title        = "Protein {BLAST}: search protein databases using a protein
                  query",
  howpublished = "\url{https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins}",
  note         = "Accessed: 2019-9-26"
}

@ARTICLE{Huerta-Cepas2016-sd,
  title    = "{eggNOG} 4.5: a hierarchical orthology framework with improved
              functional annotations for eukaryotic, prokaryotic and viral
              sequences",
  author   = "Huerta-Cepas, Jaime and Szklarczyk, Damian and Forslund,
              Kristoffer and Cook, Helen and Heller, Davide and Walter, Mathias
              C and Rattei, Thomas and Mende, Daniel R and Sunagawa, Shinichi
              and Kuhn, Michael and Jensen, Lars Juhl and von Mering, Christian
              and Bork, Peer",
  abstract = "eggNOG is a public resource that provides Orthologous Groups
              (OGs) of proteins at different taxonomic levels, each with
              integrated and summarized functional annotations. Developments
              since the latest public release include changes to the algorithm
              for creating OGs across taxonomic levels, making nested groups
              hierarchically consistent. This allows for a better propagation
              of functional terms across nested OGs and led to the novel
              annotation of 95 890 previously uncharacterized OGs, increasing
              overall annotation coverage from 67\% to 72\%. The functional
              annotations of OGs have been expanded to also provide Gene
              Ontology terms, KEGG pathways and SMART/Pfam domains for each
              group. Moreover, eggNOG now provides pairwise orthology
              relationships within OGs based on analysis of phylogenetic trees.
              We have also incorporated a framework for quickly mapping novel
              sequences to OGs based on precomputed HMM profiles. Finally,
              eggNOG version 4.5 incorporates a novel data set spanning 2605
              viral OGs, covering 5228 proteins from 352 viral proteomes. All
              data are accessible for bulk downloading, as a web-service, and
              through a completely redesigned web interface. The new access
              points provide faster searches and a number of new browsing and
              visualization capabilities, facilitating the needs of both
              experts and less experienced users. eggNOG v4.5 is available at
              http://eggnog.embl.de.",
  journal  = "Nucleic Acids Res.",
  volume   =  44,
  number   = "D1",
  pages    = "D286--93",
  month    =  jan,
  year     =  2016,
  language = "en"
}

@ARTICLE{Liebermeister2014-me,
  title    = "Visual account of protein investment in cellular functions",
  author   = "Liebermeister, Wolfram and Noor, Elad and Flamholz, Avi and
              Davidi, Dan and Bernhardt, J{\"o}rg and Milo, Ron",
  abstract = "Proteomics techniques generate an avalanche of data and promise
              to satisfy biologists' long-held desire to measure absolute
              protein abundances on a genome-wide scale. However, can this
              knowledge be translated into a clearer picture of how cells
              invest their protein resources? This article aims to give a broad
              perspective on the composition of proteomes as gleaned from
              recent quantitative proteomics studies. We describe proteomaps,
              an approach for visualizing the composition of proteomes with a
              focus on protein abundances and functions. In proteomaps, each
              protein is shown as a polygon-shaped tile, with an area
              representing protein abundance. Functionally related proteins
              appear in adjacent regions. General trends in proteomes, such as
              the dominance of metabolism and protein production, become easily
              visible. We make interactive visualizations of published proteome
              datasets accessible at www.proteomaps.net. We suggest that
              evaluating the way protein resources are allocated by various
              organisms and cell types in different conditions will sharpen our
              understanding of how and why cells regulate the composition of
              their proteomes.",
  journal  = "Proc. Natl. Acad. Sci. U. S. A.",
  volume   =  111,
  number   =  23,
  pages    = "8488--8493",
  month    =  jun,
  year     =  2014,
  keywords = "Voronoi treemap; cell resource allocation; cellular economy;
              functional classification; mass spectrometry",
  language = "en"
}

@ARTICLE{Almagro_Armenteros2017-ne,
  title    = "{DeepLoc}: prediction of protein subcellular localization using
              deep learning",
  author   = "Almagro Armenteros, Jos{\'e} Juan and S{\o}nderby, Casper Kaae
              and S{\o}nderby, S{\o}ren Kaae and Nielsen, Henrik and Winther,
              Ole",
  abstract = "Motivation: The prediction of eukaryotic protein subcellular
              localization is a well-studied topic in bioinformatics due to its
              relevance in proteomics research. Many machine learning methods
              have been successfully applied in this task, but in most of them,
              predictions rely on annotation of homologues from knowledge
              databases. For novel proteins where no annotated homologues
              exist, and for predicting the effects of sequence variants, it is
              desirable to have methods for predicting protein properties from
              sequence information only. Results: Here, we present a prediction
              algorithm using deep neural networks to predict protein
              subcellular localization relying only on sequence information. At
              its core, the prediction model uses a recurrent neural network
              that processes the entire protein sequence and an attention
              mechanism identifying protein regions important for the
              subcellular localization. The model was trained and tested on a
              protein dataset extracted from one of the latest UniProt
              releases, in which experimentally annotated proteins follow more
              stringent criteria than previously. We demonstrate that our model
              achieves a good accuracy (78\% for 10 categories; 92\% for
              membrane-bound or soluble), outperforming current
              state-of-the-art algorithms, including those relying on homology
              information. Availability and implementation: The method is
              available as a web server at
              http://www.cbs.dtu.dk/services/DeepLoc. Example code is available
              at https://github.com/JJAlmagro/subcellular\_localization. The
              dataset is available at
              http://www.cbs.dtu.dk/services/DeepLoc/data.php. Contact:
              jjalma@dtu.dk.",
  journal  = "Bioinformatics",
  volume   =  33,
  number   =  21,
  pages    = "3387--3395",
  month    =  nov,
  year     =  2017,
  language = "en"
}

@ARTICLE{Almagro_Armenteros2019-ty,
  title    = "{SignalP} 5.0 improves signal peptide predictions using deep
              neural networks",
  author   = "Almagro Armenteros, Jos{\'e} Juan and Tsirigos, Konstantinos D
              and S{\o}nderby, Casper Kaae and Petersen, Thomas Nordahl and
              Winther, Ole and Brunak, S{\o}ren and von Heijne, Gunnar and
              Nielsen, Henrik",
  abstract = "Signal peptides (SPs) are short amino acid sequences in the amino
              terminus of many newly synthesized proteins that target proteins
              into, or across, membranes. Bioinformatic tools can predict SPs
              from amino acid sequences, but most cannot distinguish between
              various types of signal peptides. We present a deep neural
              network-based approach that improves SP prediction across all
              domains of life and distinguishes between three types of
              prokaryotic SPs.",
  journal  = "Nat. Biotechnol.",
  volume   =  37,
  number   =  4,
  pages    = "420--423",
  month    =  apr,
  year     =  2019,
  language = "en"
}

@ARTICLE{Tsirigos2015-ab,
  title    = "The {TOPCONS} web server for consensus prediction of membrane
              protein topology and signal peptides",
  author   = "Tsirigos, Konstantinos D and Peters, Christoph and Shu, Nanjiang
              and K{\"a}ll, Lukas and Elofsson, Arne",
  abstract = "TOPCONS (http://topcons.net/) is a widely used web server for
              consensus prediction of membrane protein topology. We hereby
              present a major update to the server, with some substantial
              improvements, including the following: (i) TOPCONS can now
              efficiently separate signal peptides from transmembrane regions.
              (ii) The server can now differentiate more successfully between
              globular and membrane proteins. (iii) The server now is even
              slightly faster, although a much larger database is used to
              generate the multiple sequence alignments. For most proteins, the
              final prediction is produced in a matter of seconds. (iv) The
              user-friendly interface is retained, with the additional feature
              of submitting batch files and accessing the server
              programmatically using standard interfaces, making it thus ideal
              for proteome-wide analyses. Indicatively, the user can now scan
              the entire human proteome in a few days. (v) For proteins with
              homology to a known 3D structure, the homology-inferred topology
              is also displayed. (vi) Finally, the combination of methods
              currently implemented achieves an overall increase in performance
              by 4\% as compared to the currently available best-scoring
              methods and TOPCONS is the only method that can identify signal
              peptides and still maintain a state-of-the-art performance in
              topology predictions.",
  journal  = "Nucleic Acids Res.",
  volume   =  43,
  number   = "W1",
  pages    = "W401--7",
  month    =  jul,
  year     =  2015,
  language = "en"
}

@ARTICLE{Manfrao-Netto2019-ti,
  title    = "Advances in Using Hansenula polymorpha as Chassis for Recombinant
              Protein Production",
  author   = "Manfr{\~a}o-Netto, Jo{\~a}o Heitor Colombelli and Gomes,
              Ant{\^o}nio Milton Vieira and Parachin, N{\'a}dia Skorupa",
  abstract = "The methylotrophic yeast Hansenula polymorpha, known as a
              non-conventional yeast, is used for the last 30 years for the
              production of recombinant proteins, including enzymes, vaccines,
              and biopharmaceuticals. Although a large number of reviews have
              been published elucidating the applications of this yeast as a
              cell factory, the latest was released about 10 years ago.
              Therefore, this review aimed at summarizing available information
              on the use of H. polymorpha as a host for recombinant protein
              production in the last decade. Examples of chemicals and
              virus-like particles produced using this yeast also are
              discussed. Firstly, the aspects that feature this yeast as a host
              for recombinant protein production are highlighted including the
              techniques available for its genetic manipulation as well as
              strategies for cultivation in bioreactors. Special attention is
              given to the novel genomic editing tools, mainly CRISPR/Cas9 that
              was recently established in this yeast. Finally, recent examples
              of using H. polymorpha as an expression platform are presented
              and discussed. The production of human Parathyroid Hormone (PTH)
              and Staphylokinase (SAK) in H. polymorpha are described as case
              studies for process establishment in this yeast. Altogether, this
              review is a guideline for this yeast utilization as an expression
              platform bringing a thorough analysis of the genetic aspects and
              fermentation protocols used up to date, thus encouraging the
              production of novel biomolecules in H. polymorpha.",
  journal  = "Front Bioeng Biotechnol",
  volume   =  7,
  pages    = "94",
  month    =  may,
  year     =  2019,
  keywords = "Hansenula polymorpha; bioprocess; genomic editing; methylotrophic
              yeast; recombinant protein",
  language = "en"
}

@UNPUBLISHED{Blevins2019-ce,
  title    = "Extensive post-transcriptional buffering of gene expression in
              the response to oxidative stress in baker's yeast",
  author   = "Blevins, William R and Tavella, Teresa and Moro, Simone G and
              Blasco-Moreno, Bernat and Closa-Mosquera, Adri{\`a} and
              D{\'i}ez, Juana and Carey, Lucas B and Mar Alb{\`a}, M",
  abstract = "Abstract Cells responds to diverse stimuli by changing the levels
              of specific effector proteins. These changes are usually examined
              using high throughput RNA sequencing data (RNA-Seq);
              transcriptional regulation is generally assumed to directly
              influence protein abundances. However, the correlation between
              RNA-Seq and proteomics data is in general quite limited owing to
              differences in protein stability and translational regulation.
              Here we perform RNA-Seq, ribosome profiling and proteomics
              analyses in baker's yeast cells grow in rich media and oxidative
              stress conditions to examine gene expression regulation at
              various levels. With the exception of a small set of genes
              involved in the maintenance of the redox state, which are
              regulated at the transcriptional level, modulation of protein
              expression is largely driven by changes in the relative ribosome
              density across conditions. The majority of shifts in mRNA
              abundance are compensated by changes in the opposite direction in
              the number of translating ribosomes and are predicted to result
              in no net change in protein level. We also identify a subset of
              mRNAs which is likely to undergo specific translational
              repression during stress and which includes cell cycle control
              genes. The study suggests that post-transcriptional buffering of
              gene expression may be more common than previously anticipated.",
  journal  = "bioRxiv",
  pages    = "501478",
  month    =  apr,
  year     =  2019,
  language = "en"
}
@ARTICLE{Dillies2013-xw,
  title    = "A comprehensive evaluation of normalization methods for Illumina
              high-throughput {RNA} sequencing data analysis",
  author   = "Dillies, Marie-Agn{\`e}s and Rau, Andrea and Aubert, Julie and
              Hennequet-Antier, Christelle and Jeanmougin, Marine and Servant,
              Nicolas and Keime, C{\'e}line and Marot, Guillemette and Castel,
              David and Estelle, Jordi and Guernec, Gregory and Jagla, Bernd
              and Jouneau, Luc and Lalo{\"e}, Denis and Le Gall, Caroline and
              Scha{\"e}ffer, Brigitte and Le Crom, St{\'e}phane and Guedj,
              Micka{\"e}l and Jaffr{\'e}zic, Florence and {French StatOmique
              Consortium}",
  abstract = "During the last 3 years, a number of approaches for the
              normalization of RNA sequencing data have emerged in the
              literature, differing both in the type of bias adjustment and in
              the statistical strategy adopted. However, as data continue to
              accumulate, there has been no clear consensus on the appropriate
              normalization method to be used or the impact of a chosen method
              on the downstream analysis. In this work, we focus on a
              comprehensive comparison of seven recently proposed normalization
              methods for the differential analysis of RNA-seq data, with an
              emphasis on the use of varied real and simulated datasets
              involving different species and experimental designs to represent
              data characteristics commonly observed in practice. Based on this
              comparison study, we propose practical recommendations on the
              appropriate normalization method to be used and its impact on the
              differential analysis of RNA-seq data.",
  journal  = "Brief. Bioinform.",
  volume   =  14,
  number   =  6,
  pages    = "671--683",
  month    =  nov,
  year     =  2013,
  keywords = "RNA-seq; differential analysis; high-throughput sequencing;
              normalization",
  language = "en"
}
@ARTICLE{Wagner2012-le,
  title    = "Measurement of {mRNA} abundance using {RNA-seq} data: {RPKM}
              measure is inconsistent among samples",
  author   = "Wagner, G{\"u}nter P and Kin, Koryu and Lynch, Vincent J",
  abstract = "Measures of RNA abundance are important for many areas of biology
              and often obtained from high-throughput RNA sequencing methods
              such as Illumina sequence data. These measures need to be
              normalized to remove technical biases inherent in the sequencing
              approach, most notably the length of the RNA species and the
              sequencing depth of a sample. These biases are corrected in the
              widely used reads per kilobase per million reads (RPKM) measure.
              Here, we argue that the intended meaning of RPKM is a measure of
              relative molar RNA concentration (rmc) and show that for each set
              of transcripts the average rmc is a constant, namely the inverse
              of the number of transcripts mapped. Further, we show that RPKM
              does not respect this invariance property and thus cannot be an
              accurate measure of rmc. We propose a slight modification of RPKM
              that eliminates this inconsistency and call it TPM for
              transcripts per million. TPM respects the average invariance and
              eliminates statistical biases inherent in the RPKM measure.",
  journal  = "Theory Biosci.",
  volume   =  131,
  number   =  4,
  pages    = "281--285",
  month    =  dec,
  year     =  2012,
  language = "en"
}

@ARTICLE{Haas2013-eb,
  title    = "De novo transcript sequence reconstruction from {RNA-seq} using
              the Trinity platform for reference generation and analysis",
  author   = "Haas, Brian J and Papanicolaou, Alexie and Yassour, Moran and
              Grabherr, Manfred and Blood, Philip D and Bowden, Joshua and
              Couger, Matthew Brian and Eccles, David and Li, Bo and Lieber,
              Matthias and MacManes, Matthew D and Ott, Michael and Orvis,
              Joshua and Pochet, Nathalie and Strozzi, Francesco and Weeks,
              Nathan and Westerman, Rick and William, Thomas and Dewey, Colin N
              and Henschel, Robert and LeDuc, Richard D and Friedman, Nir and
              Regev, Aviv",
  abstract = "De novo assembly of RNA-seq data enables researchers to study
              transcriptomes without the need for a genome sequence; this
              approach can be usefully applied, for instance, in research on
              'non-model organisms' of ecological and evolutionary importance,
              cancer samples or the microbiome. In this protocol we describe
              the use of the Trinity platform for de novo transcriptome
              assembly from RNA-seq data in non-model organisms. We also
              present Trinity-supported companion utilities for downstream
              applications, including RSEM for transcript abundance estimation,
              R/Bioconductor packages for identifying differentially expressed
              transcripts across samples and approaches to identify
              protein-coding genes. In the procedure, we provide a workflow for
              genome-independent transcriptome analysis leveraging the Trinity
              platform. The software, documentation and demonstrations are
              freely available from http://trinityrnaseq.sourceforge.net. The
              run time of this protocol is highly dependent on the size and
              complexity of data to be analyzed. The example data set analyzed
              in the procedure detailed herein can be processed in less than 5
              h.",
  journal  = "Nat. Protoc.",
  volume   =  8,
  number   =  8,
  pages    = "1494--1512",
  month    =  aug,
  year     =  2013,
  language = "en"
}

@ARTICLE{Pertea2015-nd,
  title    = "{StringTie} enables improved reconstruction of a transcriptome
              from {RNA-seq} reads",
  author   = "Pertea, Mihaela and Pertea, Geo M and Antonescu, Corina M and
              Chang, Tsung-Cheng and Mendell, Joshua T and Salzberg, Steven L",
  abstract = "Methods used to sequence the transcriptome often produce more
              than 200 million short sequences. We introduce StringTie, a
              computational method that applies a network flow algorithm
              originally developed in optimization theory, together with
              optional de novo assembly, to assemble these complex data sets
              into transcripts. When used to analyze both simulated and real
              data sets, StringTie produces more complete and accurate
              reconstructions of genes and better estimates of expression
              levels, compared with other leading transcript assembly programs
              including Cufflinks, IsoLasso, Scripture and Traph. For example,
              on 90 million reads from human blood, StringTie correctly
              assembled 10,990 transcripts, whereas the next best assembly was
              of 7,187 transcripts by Cufflinks, which is a 53\% increase in
              transcripts assembled. On a simulated data set, StringTie
              correctly assembled 7,559 transcripts, which is 20\% more than
              the 6,310 assembled by Cufflinks. As well as producing a more
              complete transcriptome assembly, StringTie runs faster on all
              data sets tested to date compared with other assembly software,
              including Cufflinks.",
  journal  = "Nat. Biotechnol.",
  volume   =  33,
  number   =  3,
  pages    = "290--295",
  month    =  mar,
  year     =  2015,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Li2018-wf,
  title    = "Minimap2: pairwise alignment for nucleotide sequences",
  author   = "Li, Heng",
  abstract = "Motivation: Recent advances in sequencing technologies promise
              ultra-long reads of âˆ¼100 kb in average, full-length mRNA or cDNA
              reads in high throughput and genomic contigs over 100 Mb in
              length. Existing alignment programs are unable or inefficient to
              process such data at scale, which presses for the development of
              new alignment algorithms. Results: Minimap2 is a general-purpose
              alignment program to map DNA or long mRNA sequences against a
              large reference database. It works with accurate short reads of
              $\geq$100 bp in length, $\geq$1 kb genomic reads at error rate
              âˆ¼15\%, full-length noisy Direct RNA or cDNA reads and assembly
              contigs or closely related full chromosomes of hundreds of
              megabases in length. Minimap2 does split-read alignment, employs
              concave gap cost for long insertions and deletions and introduces
              new heuristics to reduce spurious alignments. It is 3-4 times as
              fast as mainstream short-read mappers at comparable accuracy, and
              is $\geq$30 times faster than long-read genomic or cDNA mappers
              at higher accuracy, surpassing most aligners specialized in one
              type of alignment. Availability and implementation:
              https://github.com/lh3/minimap2. Supplementary information:
              Supplementary data are available at Bioinformatics online.",
  journal  = "Bioinformatics",
  volume   =  34,
  number   =  18,
  pages    = "3094--3100",
  month    =  sep,
  year     =  2018,
  language = "en"
}

@ARTICLE{Testa2015-py,
  title    = "{CodingQuarry}: highly accurate hidden Markov model gene
              prediction in fungal genomes using {RNA-seq} transcripts",
  author   = "Testa, Alison C and Hane, James K and Ellwood, Simon R and
              Oliver, Richard P",
  abstract = "BACKGROUND: The impact of gene annotation quality on functional
              and comparative genomics makes gene prediction an important
              process, particularly in non-model species, including many fungi.
              Sets of homologous protein sequences are rarely complete with
              respect to the fungal species of interest and are often small or
              unreliable, especially when closely related species have not been
              sequenced or annotated in detail. In these cases, protein
              homology-based evidence fails to correctly annotate many genes,
              or significantly improve ab initio predictions. Generalised
              hidden Markov models (GHMM) have proven to be invaluable tools in
              gene annotation and, recently, RNA-seq has emerged as a
              cost-effective means to significantly improve the quality of
              automated gene annotation. As these methods do not require sets
              of homologous proteins, improving gene prediction from these
              resources is of benefit to fungal researchers. While many
              pipelines now incorporate RNA-seq data in training GHMMs, there
              has been relatively little investigation into additionally
              combining RNA-seq data at the point of prediction, and room for
              improvement in this area motivates this study. RESULTS:
              CodingQuarry is a highly accurate, self-training GHMM fungal gene
              predictor designed to work with assembled, aligned RNA-seq
              transcripts. RNA-seq data informs annotations both during
              gene-model training and in prediction. Our approach capitalises
              on the high quality of fungal transcript assemblies by
              incorporating predictions made directly from transcript
              sequences. Correct predictions are made despite transcript
              assembly problems, including those caused by overlap between the
              transcripts of adjacent gene loci. Stringent benchmarking against
              high-confidence annotation subsets showed CodingQuarry predicted
              91.3\% of Schizosaccharomyces pombe genes and 90.4\% of
              Saccharomyces cerevisiae genes perfectly. These results are 4-5\%
              better than those of AUGUSTUS, the next best performing RNA-seq
              driven gene predictor tested. Comparisons against whole genome
              Sc. pombe and S. cerevisiae annotations further substantiate a
              4-5\% improvement in the number of correctly predicted genes.
              CONCLUSIONS: We demonstrate the success of a novel method of
              incorporating RNA-seq data into GHMM fungal gene prediction. This
              shows that a high quality annotation can be achieved without
              relying on protein homology or a training set of genes.
              CodingQuarry is freely available (
              https://sourceforge.net/projects/codingquarry/ ), and suitable
              for incorporation into genome annotation pipelines.",
  journal  = "BMC Genomics",
  volume   =  16,
  pages    = "170",
  month    =  mar,
  year     =  2015,
  language = "en"
}

@ARTICLE{Majoros2004-ji,
  title    = "{TigrScan} and {GlimmerHMM}: two open source ab initio eukaryotic
              gene-finders",
  author   = "Majoros, W H and Pertea, M and Salzberg, S L",
  abstract = "UNLABELLED: We describe two new Generalized Hidden Markov Model
              implementations for ab initio eukaryotic gene prediction. The
              C/C++ source code for both is available as open source and is
              highly reusable due to their modular and extensible
              architectures. Unlike most of the currently available
              gene-finders, the programs are re-trainable by the end user. They
              are also re-configurable and include several types of
              probabilistic submodels which can be independently combined, such
              as Maximal Dependence Decomposition trees and interpolated Markov
              models. Both programs have been used at TIGR for the annotation
              of the Aspergillus fumigatus and Toxoplasma gondii genomes.
              AVAILABILITY: Source code and documentation are available under
              the open source Artistic License from
              http://www.tigr.org/software/pirate",
  journal  = "Bioinformatics",
  volume   =  20,
  number   =  16,
  pages    = "2878--2879",
  month    =  nov,
  year     =  2004,
  language = "en"
}

@ARTICLE{Haas2008-kf,
  title    = "Automated eukaryotic gene structure annotation using
              {EVidenceModeler} and the Program to Assemble Spliced Alignments",
  author   = "Haas, Brian J and Salzberg, Steven L and Zhu, Wei and Pertea,
              Mihaela and Allen, Jonathan E and Orvis, Joshua and White, Owen
              and Buell, C Robin and Wortman, Jennifer R",
  abstract = "EVidenceModeler (EVM) is presented as an automated eukaryotic
              gene structure annotation tool that reports eukaryotic gene
              structures as a weighted consensus of all available evidence.
              EVM, when combined with the Program to Assemble Spliced
              Alignments (PASA), yields a comprehensive, configurable
              annotation system that predicts protein-coding genes and
              alternatively spliced isoforms. Our experiments on both rice and
              human genome sequences demonstrate that EVM produces automated
              gene structure annotation approaching the quality of manual
              curation.",
  journal  = "Genome Biol.",
  volume   =  9,
  number   =  1,
  pages    = "R7",
  month    =  jan,
  year     =  2008,
  language = "en"
}

@MISC{Palmer2019-ww,
  title  = "nextgenusfs/funannotate: funannotate v1.5.3",
  author = "Palmer, Jon and Stajich, Jason",
  month  =  mar,
  year   =  2019
}

@misc{Charles2013,
  author = {Charles, P.W.D.},
  title = {Project Title},
  year = {2013},
  publisher = {GitHub},
  journal = {GitHub repository},
  howpublished = {\url{https://github.com/charlespwd/project-title}},
  commit = {4f57d6a0e4c030202a07a60bc1bb1ed1544bf679}
}

@ARTICLE{Herbert2018-yo,
  title    = "Cross-site comparison of ribosomal depletion kits for Illumina
              {RNAseq} library construction",
  author   = "Herbert, Zachary T and Kershner, Jamie P and Butty, Vincent L and
              Thimmapuram, Jyothi and Choudhari, Sulbha and Alekseyev, Yuriy O
              and Fan, Jun and Podnar, Jessica W and Wilcox, Edward and Gipson,
              Jenny and Gillaspy, Allison and Jepsen, Kristen and BonDurant,
              Sandra Splinter and Morris, Krystalynne and Berkeley, Maura and
              LeClerc, Ashley and Simpson, Stephen D and Sommerville, Gary and
              Grimmett, Leslie and Adams, Marie and Levine, Stuart S",
  abstract = "BACKGROUND: Ribosomal RNA (rRNA) comprises at least 90\% of total
              RNA extracted from mammalian tissue or cell line samples.
              Informative transcriptional profiling using massively parallel
              sequencing technologies requires either enrichment of mature
              poly-adenylated transcripts or targeted depletion of the rRNA
              fraction. The latter method is of particular interest because it
              is compatible with degraded samples such as those extracted from
              FFPE and also captures transcripts that are not poly-adenylated
              such as some non-coding RNAs. Here we provide a cross-site study
              that evaluates the performance of ribosomal RNA removal kits from
              Illumina, Takara/Clontech, Kapa Biosystems, Lexogen, New England
              Biolabs and Qiagen on intact and degraded RNA samples. RESULTS:
              We find that all of the kits are capable of performing
              significant ribosomal depletion, though there are differences in
              their ease of use. All kits were able to remove ribosomal RNA to
              below 20\% with intact RNA and identify ~ 14,000 protein coding
              genes from the Universal Human Reference RNA sample at >1FPKM.
              Analysis of differentially detected genes between kits suggests
              that transcript length may be a key factor in library production
              efficiency. CONCLUSIONS: These results provide a roadmap for labs
              on the strengths of each of these methods and how best to utilize
              them.",
  journal  = "BMC Genomics",
  volume   =  19,
  number   =  1,
  pages    = "199",
  month    =  mar,
  year     =  2018,
  keywords = "ABRF; Illumina; NGS; RNAseq; Transcriptomics; rRNA depletion",
  language = "en"
}

@ARTICLE{Chung2015-bi,
  title    = "The use of duplex-specific nuclease in ribosome profiling and a
              user-friendly software package for Ribo-seq data analysis",
  author   = "Chung, Betty Y and Hardcastle, Thomas J and Jones, Joshua D and
              Irigoyen, Nerea and Firth, Andrew E and Baulcombe, David C and
              Brierley, Ian",
  abstract = "Ribosome profiling is a technique that permits genome-wide,
              quantitative analysis of translation and has found broad
              application in recent years. Here we describe a modified
              profiling protocol and software package designed to benefit more
              broadly the translation community in terms of simplicity and
              utility. The protocol, applicable to diverse organisms, including
              organelles, is based largely on previously published profiling
              methodologies, but uses duplex-specific nuclease (DSN) as a
              convenient, species-independent way to reduce rRNA contamination.
              We show that DSN-based depletion compares favorably with other
              commonly used rRNA depletion strategies and introduces little
              bias. The profiling protocol typically produces high levels of
              triplet periodicity, facilitating the detection of coding
              sequences, including upstream, downstream, and overlapping open
              reading frames (ORFs) and an alternative ribosome conformation
              evident during termination of protein synthesis. In addition, we
              provide a software package that presents a set of methods for
              parsing ribosomal profiling data from multiple samples, aligning
              reads to coding sequences, inferring alternative ORFs, and
              plotting average and transcript-specific aspects of the data.
              Methods are also provided for extracting the data in a form
              suitable for differential analysis of translation and
              translational efficiency.",
  journal  = "RNA",
  volume   =  21,
  number   =  10,
  pages    = "1731--1745",
  month    =  oct,
  year     =  2015,
  keywords = "Chlamydomonas; duplex-specific nuclease; mouse; ribosome
              profiling; translation",
  language = "en"
}

@MANUAL{noauthor_2014-so,
  title        = "Pichia Expression Kit",
  abstract     = "Pichia Expression Kit",
  year         =  2014,
  organization = "Life Technologies"
}

@ARTICLE{Anguizola2013-wo,
  title    = "Review: Glycation of human serum albumin",
  author   = "Anguizola, Jeanethe and Matsuda, Ryan and Barnaby, Omar S and
              Hoy, K S and Wa, Chunling and DeBolt, Erin and Koke, Michelle and
              Hage, David S",
  abstract = "Glycation involves the non-enzymatic addition of reducing sugars
              and/or their reactive degradation products to amine groups on
              proteins. This process is promoted by the presence of elevated
              blood glucose concentrations in diabetes and occurs with various
              proteins that include human serum albumin (HSA). This review
              examines work that has been conducted in the study and analysis
              of glycated HSA. The general structure and properties of HSA are
              discussed, along with the reactions that can lead to modification
              of this protein during glycation. The use of glycated HSA as a
              short-to-intermediate term marker for glycemic control in
              diabetes is examined, and approaches that have been utilized for
              measuring glycated HSA are summarized. Structural studies of
              glycated HSA are reviewed, as acquired for both in vivo and in
              vitro glycated HSA, along with data that have been obtained on
              the rate and thermodynamics of HSA glycation. In addition, this
              review considers various studies that have investigated the
              effects of glycation on the binding of HSA with drugs, fatty
              acids and other solutes and the potential clinical significance
              of these effects.",
  journal  = "Clin. Chim. Acta",
  volume   =  425,
  pages    = "64--76",
  month    =  oct,
  year     =  2013,
  keywords = "Diabetes; Drug--protein binding; Glycated albumin; Glycation;
              Human serum albumin; Protein modification",
  language = "en"
}

@ARTICLE{Tarca2007-zq,
  title    = "Machine learning and its applications to biology",
  author   = "Tarca, Adi L and Carey, Vincent J and Chen, Xue-Wen and Romero,
              Roberto and Dr{\u a}ghici, Sorin",
  journal  = "PLoS Comput. Biol.",
  volume   =  3,
  number   =  6,
  pages    = "e116",
  month    =  jun,
  year     =  2007,
  language = "en"
}

@ARTICLE{Pedregosa2011-qj,
  title     = "Scikit-learn: Machine Learning in Python",
  author    = "Pedregosa, Fabian and Varoquaux, Ga{\"e}l and Gramfort,
               Alexandre and Michel, Vincent and Thirion, Bertrand and Grisel,
               Olivier and Blondel, Mathieu and Prettenhofer, Peter and Weiss,
               Ron and Dubourg, Vincent and Vanderplas, Jake and Passos,
               Alexandre and Cournapeau, David and Brucher, Matthieu and
               Perrot, Matthieu and Duchesnay, {\'E}douard",
  journal   = "J. Mach. Learn. Res.",
  publisher = "JMLR.org",
  volume    =  12,
  pages     = "2825--2830",
  month     =  nov,
  year      =  2011
}

@ARTICLE{Mrsa1999-ok,
  title    = "Deletion of new covalently linked cell wall glycoproteins alters
              the electrophoretic mobility of phosphorylated wall components of
              Saccharomyces cerevisiae",
  author   = "Mrsa, V and Ecker, M and Strahl-Bolsinger, S and Nimtz, M and
              Lehle, L and Tanner, W",
  abstract = "The incorporation of radioactive orthophosphate into the cell
              walls of Saccharomyces cerevisiae was studied. 33P-labeled cell
              walls were extensively extracted with hot sodium dodecyl sulfate
              (SDS). Of the remaining insoluble radioactivity more than 90\%
              could be released by laminarinase. This radioactive material
              stayed in the stacking gel during SDS-polyacrylamide gel
              electrophoresis but entered the separating gel upon treatment
              with N-glycosidase F, indicating that phosphate was linked
              directly or indirectly to N-mannosylated glycoproteins. The
              phosphate was bound to covalently linked cell wall proteins as
              mannose-6-phosphate, the same type of linkage shown previously
              for soluble mannoproteins (L. Ballou, L. M. Hernandez, E.
              Alvarado, and C. E. Ballou, Proc. Natl. Acad. Sci. USA
              87:3368-3372, 1990). From the phosphate-labeled glycoprotein
              fraction released by laminarinase, three cell wall mannoproteins,
              Ccw12p, Ccw13p and Ccw14p, were isolated and identified by
              N-terminal sequencing. For Ccw13p (encoded by DAN1 [also called
              TIR3]) and Ccw12p the association with the cell wall has not been
              described before; Ccw14p is identical with cell wall protein Icwp
              (I. Moukadiri, J. Armero, A. Abad, R. Sentandreu, and J. Zueco,
              J. Bacteriol. 179:2154-2162, 1997). In ccw12, ccw13, or ccw14
              single or double mutants neither the amount of radioactive
              phosphate incorporated into cell wall proteins nor its position
              in the stacking gel was changed. However, the triple mutant
              brought about a shift of the 33P-labeled glycoprotein components
              from the stacking gel into the separating gel. The disruption of
              CCW12 results in a pronounced sensitivity of the cells to
              calcofluor white and Congo red. In addition, the ccw12 mutant
              shows a decrease in mating efficiency and a defect in
              agglutination.",
  journal  = "J. Bacteriol.",
  volume   =  181,
  number   =  10,
  pages    = "3076--3086",
  month    =  may,
  year     =  1999,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Kjellerup2017-ku,
  title    = "Identification of Antifungal {H+-ATPase} Inhibitors with Effect
              on Plasma Membrane Potential",
  author   = "Kjellerup, Lasse and Gordon, Sandra and Cohrt, Karen O'hanlon and
              Brown, William Dalby and Fuglsang, Anja Thoe and Winther,
              Anne-Marie L",
  abstract = "The plasma membrane H+-ATPase (Pma1) is an essential fungal
              protein and a proposed target for new antifungal medications. The
              compounds in a small-molecule library containing âˆ¼191,000
              commercially available compounds were screened for their ability
              to inhibit Saccharomyces cerevisiae plasma membranes containing
              Pma1. The overall hit rate was 0.2\%, corresponding to 407
              compounds. These hit compounds were further evaluated for ATPase
              selectivity and broad-spectrum antifungal activity. Following
              this work, one Pma1 inhibitor series based on compound 14 and
              analogs was selected for further evaluation. This compound series
              was able to depolarize the membrane and inhibit extracellular
              acidification in intact fungal cells concomitantly with a
              significant increase in intracellular ATP levels. Collectively,
              we suggest that these effects may be a common feature of Pma1
              inhibitors. Additionally, the work uncovered a dual mechanism for
              the previously identified cationic peptide BM2, revealing fungal
              membrane disruption, in addition to Pma1 inhibition. The methods
              presented here provide a solid platform for the evaluation of
              Pma1-specific inhibitors in a drug development setting. The
              present inhibitors could serve as a starting point for the
              development of new antifungal agents with a novel mode of action.",
  journal  = "Antimicrob. Agents Chemother.",
  volume   =  61,
  number   =  7,
  month    =  jul,
  year     =  2017,
  keywords = "ATPase; antifungal agents; drug development; membrane proteins",
  language = "en"
}

@ARTICLE{Gupta2008-fe,
  title   = "Production and Characterization of {{\^I}$\pm$-Amylase} from
             Aspergillus niger",
  author  = "Gupta, A and Gupta, V K and Modi, D R and Yadava, L P",
  journal = "Biotechnology",
  volume  =  7,
  number  =  3,
  pages   = "551--556",
  month   =  mar,
  year    =  2008
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Kulshrestha2013-gj,
  title    = "Invertase and its applications -- A brief review",
  author   = "Kulshrestha, Samarth and Tyagi, Prasidhi and Sindhi, Vinita and
              Yadavilli, Kameshwar Sharma",
  abstract = "Invertase, also called beta-fructofuranosidase cleaving the
              terminal non-reducing beta-fructofuranoside residues, is a
              glycoprotein with an optimum pH 4.5 and stability at 50 Â°C. It is
              widely distributed in the biosphere especially in plants and
              microorganisms. Saccharomyces cerevisiae commonly called baker's
              yeast is the chief strain used for the production and
              purification of the enzyme. Invertase in nature exists in
              different isoforms. In yeasts, it is present either as
              extracellular Invertase or intracellular Invertase. In plants,
              there are three isoforms each differing in biochemical properties
              and subcellular locations. Invertase in plants is essential not
              only for metabolism but also help in osmoregulation, development
              and defence system. In humans, the enzyme acts as an immune
              booster, as an anti-oxidant, an antiseptic and helpful for bone
              cancer or stomach cancer patients in some cases. The present
              study focuses upon the Invertase along with its application and
              purification from Saccharomyces cerevisiae. Invertase from
              baker's yeast was purified by concentrating the crude extract
              with ammonium sulphate (70\%), dialyzed using sample buffer (0.1
              M Tris, pH 7.2) and followed by centrifugation. The resultant
              supernatant was then applied on DEAE-cellulose column
              equilibrated with Tris buffer. The enzyme was eluted with a step
              gradient of NaCl (0--0.5 M) in starting buffer. Fractions showing
              highest activity were pooled. The result contains the
              purification summary with the purification fold of 27.13 and
              recovery of 31.93\%. For the better understanding the mechanism
              and structure of the purified enzyme characterization is
              essential.",
  journal  = "J. Pharm. Res.",
  volume   =  7,
  number   =  9,
  pages    = "792--797",
  month    =  sep,
  year     =  2013,
  keywords = "Antiseptic; Baker's yeast; Chromatography; Invertase;
              Purification"
}

@ARTICLE{Vieira_Gomes2018-yp,
  title    = "Comparison of Yeasts as Hosts for Recombinant Protein Production",
  author   = "Vieira Gomes, Antonio Milton and Souza Carmo, Talita and Silva
              Carvalho, Lucas and Mendon{\c c}a Bahia, Frederico and Parachin,
              N{\'a}dia Skorupa",
  abstract = "Recombinant protein production emerged in the early 1980s with
              the development of genetic engineering tools, which represented a
              compelling alternative to protein extraction from natural
              sources. Over the years, a high level of heterologous protein was
              made possible in a variety of hosts ranging from the bacteria
              Escherichia coli to mammalian cells. Recombinant protein
              importance is represented by its market size, which reached $1654
              million in 2016 and is expected to reach $2850.5 million by 2022.
              Among the available hosts, yeasts have been used for producing a
              great variety of proteins applied to chemicals, fuels, food, and
              pharmaceuticals, being one of the most used hosts for recombinant
              production nowadays. Historically, Saccharomyces cerevisiae was
              the dominant yeast host for heterologous protein production.
              Lately, other yeasts such as Komagataella sp., Kluyveromyces
              lactis, and Yarrowia lipolytica have emerged as advantageous
              hosts. In this review, a comparative analysis is done listing the
              advantages and disadvantages of using each host regarding the
              availability of genetic tools, strategies for cultivation in
              bioreactors, and the main techniques utilized for protein
              purification. Finally, examples of each host will be discussed
              regarding the total amount of protein recovered and its
              bioactivity due to correct folding and glycosylation patterns.",
  journal  = "Microorganisms",
  volume   =  6,
  number   =  2,
  month    =  apr,
  year     =  2018,
  keywords = "Kluyveromyces lactis; Komagataella phaffii; Saccharomyces
              cerevisiae; Yarrowia lipolytica; recombinant protein; yeast",
  language = "en"
}

@MISC{noauthor_undated-zf,
  title        = "cel7a - Glucanase - Hypocrea jecorina (strain {QM6a}) - cel7a
                  gene \& protein",
  howpublished = "\url{https://www.uniprot.org/uniprot/G0RVK1}",
  note         = "Accessed: 2019-10-31"
}

@ARTICLE{Ong2002-bs,
  title    = "Stable isotope labeling by amino acids in cell culture, {SILAC},
              as a simple and accurate approach to expression proteomics",
  author   = "Ong, Shao-En and Blagoev, Blagoy and Kratchmarova, Irina and
              Kristensen, Dan Bach and Steen, Hanno and Pandey, Akhilesh and
              Mann, Matthias",
  abstract = "Quantitative proteomics has traditionally been performed by
              two-dimensional gel electrophoresis, but recently, mass
              spectrometric methods based on stable isotope quantitation have
              shown great promise for the simultaneous and automated
              identification and quantitation of complex protein mixtures. Here
              we describe a method, termed SILAC, for stable isotope labeling
              by amino acids in cell culture, for the in vivo incorporation of
              specific amino acids into all mammalian proteins. Mammalian cell
              lines are grown in media lacking a standard essential amino acid
              but supplemented with a non-radioactive, isotopically labeled
              form of that amino acid, in this case deuterated leucine
              (Leu-d3). We find that growth of cells maintained in these media
              is no different from growth in normal media as evidenced by cell
              morphology, doubling time, and ability to differentiate. Complete
              incorporation of Leu-d3 occurred after five doublings in the cell
              lines and proteins studied. Protein populations from experimental
              and control samples are mixed directly after harvesting, and mass
              spectrometric identification is straightforward as every
              leucine-containing peptide incorporates either all normal leucine
              or all Leu-d3. We have applied this technique to the relative
              quantitation of changes in protein expression during the process
              of muscle cell differentiation. Proteins that were found to be
              up-regulated during this process include
              glyceraldehyde-3-phosphate dehydrogenase, fibronectin, and
              pyruvate kinase M2. SILAC is a simple, inexpensive, and accurate
              procedure that can be used as a quantitative proteomic approach
              in any cell culture system.",
  journal  = "Mol. Cell. Proteomics",
  volume   =  1,
  number   =  5,
  pages    = "376--386",
  month    =  may,
  year     =  2002,
  language = "en"
}

@ARTICLE{Singh2016-be,
  title    = "Investigating essential gene function in Mycobacterium
              tuberculosis using an efficient {CRISPR} interference system",
  author   = "Singh, Atul K and Carette, Xavier and Potluri, Lakshmi-Prasad and
              Sharp, Jared D and Xu, Ranfei and Prisic, Sladjana and Husson,
              Robert N",
  abstract = "Despite many methodological advances that have facilitated
              investigation of Mycobacterium tuberculosis pathogenesis,
              analysis of essential gene function in this slow-growing pathogen
              remains difficult. Here, we describe an optimized CRISPR-based
              method to inhibit expression of essential genes based on the
              inducible expression of an enzymatically inactive Cas9 protein
              together with gene-specific guide RNAs (CRISPR interference).
              Using this system to target several essential genes of M.
              tuberculosis, we achieved marked inhibition of gene expression
              resulting in growth inhibition, changes in susceptibility to
              small molecule inhibitors and disruption of normal cell
              morphology. Analysis of expression of genes containing sequences
              similar to those targeted by individual guide RNAs did not reveal
              significant off-target effects. Advantages of this approach
              include the ability to compare inhibited gene expression to
              native levels of expression, lack of the need to alter the M.
              tuberculosis chromosome, the potential to titrate the extent of
              transcription inhibition, and the ability to avoid off-target
              effects. Based on the consistent inhibition of transcription and
              the simple cloning strategy described in this work, CRISPR
              interference provides an efficient approach to investigate
              essential gene function that may be particularly useful in
              characterizing genes of unknown function and potential targets
              for novel small molecule inhibitors.",
  journal  = "Nucleic Acids Res.",
  volume   =  44,
  number   =  18,
  pages    = "e143",
  month    =  oct,
  year     =  2016,
  language = "en"
}

@ARTICLE{Larson2013-fu,
  title    = "{CRISPR} interference ({CRISPRi}) for sequence-specific control
              of gene expression",
  author   = "Larson, Matthew H and Gilbert, Luke A and Wang, Xiaowo and Lim,
              Wendell A and Weissman, Jonathan S and Qi, Lei S",
  abstract = "Sequence-specific control of gene expression on a genome-wide
              scale is an important approach for understanding gene functions
              and for engineering genetic regulatory systems. We have recently
              described an RNA-based method, CRISPR interference (CRISPRi), for
              targeted silencing of transcription in bacteria and human cells.
              The CRISPRi system is derived from the Streptococcus pyogenes
              CRISPR (clustered regularly interspaced palindromic repeats)
              pathway, requiring only the coexpression of a catalytically
              inactive Cas9 protein and a customizable single guide RNA
              (sgRNA). The Cas9-sgRNA complex binds to DNA elements
              complementary to the sgRNA and causes a steric block that halts
              transcript elongation by RNA polymerase, resulting in the
              repression of the target gene. Here we provide a protocol for the
              design, construction and expression of customized sgRNAs for
              transcriptional repression of any gene of interest. We also
              provide details for testing the repression activity of CRISPRi
              using quantitative fluorescence assays and native elongating
              transcript sequencing. CRISPRi provides a simplified approach for
              rapid gene repression within 1-2 weeks. The method can also be
              adapted for high-throughput interrogation of genome-wide gene
              functions and genetic interactions, thus providing a
              complementary approach to RNA interference, which can be used in
              a wider variety of organisms.",
  journal  = "Nat. Protoc.",
  volume   =  8,
  number   =  11,
  pages    = "2180--2196",
  month    =  nov,
  year     =  2013,
  language = "en"
}

@ARTICLE{Drinnenberg2009-zz,
  title    = "{RNAi} in budding yeast",
  author   = "Drinnenberg, Ines A and Weinberg, David E and Xie, Kathleen T and
              Mower, Jeffrey P and Wolfe, Kenneth H and Fink, Gerald R and
              Bartel, David P",
  abstract = "RNA interference (RNAi), a gene-silencing pathway triggered by
              double-stranded RNA, is conserved in diverse eukaryotic species
              but has been lost in the model budding yeast Saccharomyces
              cerevisiae. Here, we show that RNAi is present in other budding
              yeast species, including Saccharomyces castellii and Candida
              albicans. These species use noncanonical Dicer proteins to
              generate small interfering RNAs, which mostly correspond to
              transposable elements and Y' subtelomeric repeats. In S.
              castellii, RNAi mutants are viable but have excess Y' messenger
              RNA levels. In S. cerevisiae, introducing Dicer and Argonaute of
              S. castellii restores RNAi, and the reconstituted pathway
              silences endogenous retrotransposons. These results identify a
              previously unknown class of Dicer proteins, bring the tool of
              RNAi to the study of budding yeasts, and bring the tools of
              budding yeast to the study of RNAi.",
  journal  = "Science",
  volume   =  326,
  number   =  5952,
  pages    = "544--550",
  month    =  oct,
  year     =  2009,
  language = "en"
}

@ARTICLE{Kawai2010-it,
  title    = "Transformation of Saccharomyces cerevisiae and other fungi:
              methods and possible underlying mechanism",
  author   = "Kawai, Shigeyuki and Hashimoto, Wataru and Murata, Kousaku",
  abstract = "Transformation (i.e., genetic modification of a cell by the
              incorporation of exogenous DNA) is indispensable for manipulating
              fungi. Here, we review the transformation methods for
              Saccharomyces cerevisiae, Schizosaccharomyces pombe, Candida
              albicans, Pichia pastoris and Aspergillus species and discuss
              some common modifications to improve transformation efficiency.
              We also present a model of the mechanism underlying S. cerevisiae
              transformation, based on recent reports and the mechanism of
              transfection in mammalian systems. This model predicts that DNA
              attaches to the cell wall and enters the cell via endocytotic
              membrane invagination, although how DNA reaches the nucleus is
              unknown. Polyethylene glycol is indispensable for successful
              transformation of intact cells and the attachment of DNA and also
              possibly acts on the membrane to increase the transformation
              efficiency. Both lithium acetate and heat shock, which enhance
              the transformation efficiency of intact cells but not that of
              spheroplasts, probably help DNA to pass through the cell wall.",
  journal  = "Bioeng. Bugs",
  volume   =  1,
  number   =  6,
  pages    = "395--403",
  month    =  nov,
  year     =  2010,
  keywords = "Saccharomyces cerevisiae; cell wall; electroporation;
              endocytosis; fungi; lithium acetate; polyethylene glycol;
              spheroplast; transfection; transformation",
  language = "en"
}

@ARTICLE{OKeefe2019-yu,
  title    = "{siRNAs} and {shRNAs}: Tools for Protein Knockdown by Gene
              Silencing",
  author   = "O'Keefe, Erin P",
  journal  = "Materials and Methods",
  month    =  oct,
  year     =  2019
}

@BOOK{Reece2015-nj,
  title     = "Campbell Biology Australian and New Zealand Edition",
  author    = "Reece, Jane B and Meyers, Noel and Urry, Lisa A and Cain,
               Michael L and Wasserman, Steven A and Minorsky, Peter V",
  abstract  = "Over nine successful editions, CAMPBELL BIOLOGY has been
               recognised as the world's leading introductory biology textbook.
               The Australian edition of CAMPBELL BIOLOGY continues to engage
               students with its dynamic coverage of the essential elements of
               this critical discipline. It is the only biology text and media
               product that helps students to make connections across different
               core topics in biology, between text and visuals, between global
               and Australian/New Zealand biology, and from scientific study to
               the real world.The Tenth Edition of Australian CAMPBELL BIOLOGY
               helps launch students to success in biology through its clear
               and engaging narrative, superior pedagogy, and innovative use of
               art and photos to promote student learning. It continues to
               engage students with its dynamic coverage of the essential
               elements of this critical discipline. This Tenth Edition, with
               an increased focus on evolution, ensures students receive the
               most up-to-date, accurate and relevant information.",
  publisher = "Pearson Higher Education AU",
  month     =  may,
  year      =  2015,
  language  = "en"
}

@BOOK{Nelson2017-gh,
  title     = "Lehninger Principles of Biochemistry",
  author    = "Nelson, David L and Cox, Michael M",
  abstract  = "Lehninger Principles of Biochemistry is the \#1 bestseller for
               the introductory biochemistry course because it brings clarity
               and coherence to an often unwieldy discipline, offering a
               thoroughly updated survey of biochemistry's enduring principles,
               definitive discoveries, and groundbreaking new advances with
               each edition. This new Seventh Edition maintains the qualities
               that have distinguished the text since Albert Lehninger's
               original edition--clear writing, careful explanations of
               difficult concepts, helpful problem-solving support, and
               insightful communication of contemporary biochemistry's core
               ideas, new techniques, and pivotal discoveries. Again, David
               Nelson and Michael Cox introduce students to an extraordinary
               amount of exciting new findings without an overwhelming amount
               of extra discussion or detail. And with this edition, W.H.
               Freeman and Sapling Learning have teamed up to provide the
               book's richest, most completely integrated text/media learning
               experience yet, through an extraordinary new online resource:
               SaplingPlus.",
  publisher = "Macmillan Higher Education",
  month     =  jan,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Hampton2000-qp,
  title    = "{ER} stress response: getting the {UPR} hand on misfolded
              proteins",
  author   = "Hampton, R Y",
  abstract = "Unfolded proteins are constantly delivered to the ER lumen, where
              they must be removed by folding or degradation. Recent studies
              show that the 'unfolded protein response' controls essentially
              all aspects of ER function, coordinating these two fates for
              misfolded proteins in a process necessary for normal cell life.",
  journal  = "Curr. Biol.",
  volume   =  10,
  number   =  14,
  pages    = "R518--21",
  month    =  jul,
  year     =  2000,
  language = "en"
}

@ARTICLE{Klaips2018-up,
  title    = "Pathways of cellular proteostasis in aging and disease",
  author   = "Klaips, Courtney L and Jayaraj, Gopal Gunanathan and Hartl, F
              Ulrich",
  abstract = "Ensuring cellular protein homeostasis, or proteostasis, requires
              precise control of protein synthesis, folding, conformational
              maintenance, and degradation. A complex and adaptive proteostasis
              network coordinates these processes with molecular chaperones of
              different classes and their regulators functioning as major
              players. This network serves to ensure that cells have the
              proteins they need while minimizing misfolding or aggregation
              events that are hallmarks of age-associated proteinopathies,
              including neurodegenerative disorders such as Alzheimer's and
              Parkinson's diseases. It is now clear that the capacity of cells
              to maintain proteostasis undergoes a decline during aging,
              rendering the organism susceptible to these pathologies. Here we
              discuss the major proteostasis pathways in light of recent
              research suggesting that their age-dependent failure can both
              contribute to and result from disease. We consider different
              strategies to modulate proteostasis capacity, which may help
              develop urgently needed therapies for neurodegeneration and other
              age-dependent pathologies.",
  journal  = "J. Cell Biol.",
  volume   =  217,
  number   =  1,
  pages    = "51--63",
  month    =  jan,
  year     =  2018,
  language = "en"
}

@MISC{noauthor_undated-mq,
  title        = "Science Visualization | {ArtforScience} | United States",
  booktitle    = "artforscience",
  abstract     = "SCIENCE VISUALIZATION at ArtforScience, interpreting your
                  science data for grants, proposals, research papers, talks,
                  pitch decks, books, posters, and web sites",
  howpublished = "\url{https://www.artforscience.com/}",
  note         = "Accessed: 2019-11-4"
}

@ARTICLE{McGlincy2017-lb,
  title    = "Transcriptome-wide measurement of translation by ribosome
              profiling",
  author   = "McGlincy, Nicholas J and Ingolia, Nicholas T",
  abstract = "Translation is one of the fundamental processes of life. It
              comprises the assembly of polypeptides whose amino acid sequence
              corresponds to the codon sequence of an mRNA's ORF. Translation
              is performed by the ribosome; therefore, in order to understand
              translation and its regulation we must be able to determine the
              numbers and locations of ribosomes on mRNAs in vivo. Furthermore,
              we must be able to examine their redistribution in different
              physiological contexts and in response to experimental
              manipulations. The ribosome profiling method provides us with an
              opportunity to learn these locations, by sequencing a cDNA
              library derived from the short fragments of mRNA covered by the
              ribosome. Since its original description, the ribosome profiling
              method has undergone continuing development; in this article we
              describe the method's current state. Important improvements
              include: the incorporation of sample barcodes to enable library
              multiplexing, the incorporation of unique molecular identifiers
              to enable to removal of duplicated sequences, and the replacement
              of a gel-purification step with the enzymatic degradation of
              unligated linker.",
  journal  = "Methods",
  month    =  jun,
  year     =  2017,
  keywords = "High-throughput sequencing; RNA; RNA-sequencing; Ribosome;
              Ribosome profiling; Translation",
  language = "en"
}


@MISC{noauthor_undated-fy,
  title        = "{BRAR} {LAB} --- The Brar and {\"U}nal Labs",
  booktitle    = "The Brar and {\"U}nal Labs",
  abstract     = "Research directions in Gloria Brar's lab at UC-Berkeley",
  howpublished = "\url{http://www.unal-and-brar-labs.org/brar-research/}",
  note         = "Accessed: 2019-11-6"
}


@MISC{Taggart_undated-rx,
  title        = "Production of {Protein-Complex} Components Is Stoichiometric
                  and Lacks General Feedback Regulation in Eukaryotes |
                  Elsevier Enhanced Reader",
  author       = "Taggart, James C and Li, Gene-Wei",
  howpublished = "\url{https://www.sciencedirect.com/science/article/pii/S2405471218304721/pdfft?isDTMRedir=true&download=true}",
  note         = "Accessed: 2019-5-6"
}

@ARTICLE{Soneson2019-vk,
  title    = "A comprehensive examination of Nanopore native {RNA} sequencing
              for characterization of complex transcriptomes",
  author   = "Soneson, Charlotte and Yao, Yao and Bratus-Neuenschwander, Anna
              and Patrignani, Andrea and Robinson, Mark D and Hussain, Shobbir",
  abstract = "A platform for highly parallel direct sequencing of native RNA
              strands was recently described by Oxford Nanopore Technologies,
              but despite initial efforts it remains crucial to further
              investigate the technology for quantification of complex
              transcriptomes. Here we undertake native RNA sequencing of polyA
              + RNA from two human cell lines, analysing ~5.2 million aligned
              native RNA reads. To enable informative comparisons, we also
              perform relevant ONT direct cDNA- and Illumina-sequencing. We
              find that while native RNA sequencing does enable some of the
              anticipated advantages, key unexpected aspects currently hamper
              its performance, most notably the quite frequent inability to
              obtain full-length transcripts from single reads, as well as
              difficulties to unambiguously infer their true transcript of
              origin. While characterising issues that need to be addressed
              when investigating more complex transcriptomes, our study
              highlights that with some defined improvements, native RNA
              sequencing could be an important addition to the mammalian
              transcriptomics toolbox.",
  journal  = "Nat. Commun.",
  volume   =  10,
  number   =  1,
  pages    = "3359",
  month    =  jul,
  year     =  2019,
  language = "en"
}


@ARTICLE{Ahmad2014-nu,
  title       = "Protein expression in Pichia pastoris: recent achievements and
                 perspectives for heterologous protein production",
  author      = "Ahmad, Mudassar and Hirz, Melanie and Pichler, Harald and
                 Schwab, Helmut",
  abstract    = "Pichia pastoris is an established protein expression host
                 mainly applied for the production of biopharmaceuticals and
                 industrial enzymes. This methylotrophic yeast is a
                 distinguished production system for its growth to very high
                 cell densities, for the available strong and tightly regulated
                 promoters, and for the options to produce gram amounts of
                 recombinant protein per litre of culture both intracellularly
                 and in secretory fashion. However, not every protein of
                 interest is produced in or secreted by P. pastoris to such
                 high titres. Frequently, protein yields are clearly lower,
                 particularly if complex proteins are expressed that are
                 hetero-oligomers, membrane-attached or prone to proteolytic
                 degradation. The last few years have been particularly
                 fruitful because of numerous activities in improving the
                 expression of such complex proteins with a focus on either
                 protein engineering or on engineering the protein expression
                 host P. pastoris. This review refers to established tools in
                 protein expression in P. pastoris and highlights novel
                 developments in the areas of expression vector design, host
                 strain engineering and screening for high-level expression
                 strains. Breakthroughs in membrane protein expression are
                 discussed alongside numerous commercial applications of P.
                 pastoris derived proteins.",
  journal     = "Appl. Microbiol. Biotechnol.",
  volume      =  98,
  number      =  12,
  pages       = "5301--5317",
  month       =  jun,
  year        =  2014,
  language    = "en",
  original_id = "8aa2d4ee-59ea-0506-b37c-0d2529ffb270"
}

@ARTICLE{Wittrup2015-xs,
  title    = "Knocking down disease: a progress report on {siRNA} therapeutics",
  author   = "Wittrup, Anders and Lieberman, Judy",
  abstract = "Small interfering RNAs (siRNAs), which downregulate gene
              expression guided by sequence complementarity, can be used
              therapeutically to block the synthesis of disease-causing
              proteins. The main obstacle to siRNA drugs - their delivery into
              the target cell cytosol - has been overcome to allow suppression
              of liver gene expression. Here, we review the results of recent
              clinical trials of siRNA therapeutics, which show efficient and
              durable gene knockdown in the liver, with signs of promising
              clinical outcomes and little toxicity. We also discuss the
              barriers to more widespread applications that target tissues
              besides the liver and the most promising avenues to overcome
              them.",
  journal  = "Nat. Rev. Genet.",
  volume   =  16,
  number   =  9,
  pages    = "543--552",
  month    =  sep,
  year     =  2015,
  language = "en"
}


@UNPUBLISHED{Dykstra2017-hl,
  title       = "Predicting Protein Producibility In Filamentous Fungi",
  author      = "Dykstra, Karmen and Rousu, Juho and Arvas, Mikko",
  abstract    = "In this paper we study the problem of predicting the
                 producibility of recombinant proteins in filamentous fungi,
                 especially T. reesei, using machine learning methods. We train
                 supervised and semi-supervised support vector machines with
                 protein sequences, represented by their amino acid composition
                 as well as protein family and domain information. Our results
                 indicate, somewhat surprisingly, that quite modest amount of
                 proteins with experimental data are required to build a
                 state-of-the-art classifier and that additional unlabeled
                 sequences in semi-supervised models do not bring increased
                 predictive performance. Our experiments in cross-species
                 prediction show that models trained for the filamentous fungus
                 A. niger protein dataset can be generalized to predict protein
                 producibility in T. reesei, and vice versa, without
                 sacrificing too much accuracy, regardless of their
                 approximately 500 millions years of divergence. However,
                 predictors trained on E. coli and S. cerevisiae datasets gave
                 variable performance when applied to the filamentous fungi
                 datasets, indicating that while protein producibility
                 prediction can be generalized across related species, fully
                 generic prediction tools applicable to any protein production
                 host may not be realistic to achieve.",
  journal     = "bioRxiv",
  pages       = "138560",
  month       =  may,
  year        =  2017,
  language    = "en",
  original_id = "e78381b4-7921-04fb-b1dd-c4099581f1e8"
}
